# Chapter 60: Functional Neurological Symptom Disorder (Conversion Disorder)

## The Biological and Neurological Basis of Functional Neurological Symptom Disorder

### Introduction

Functional Neurological Symptom Disorder (FNSD), also known as Conversion Disorder, stands as one of the most enigmatic and clinically challenging conditions at the interface of neurology and psychiatry (Willis, 2020). Historically conceptualized under terms like "hysteria" (Roy-Byrne, 2001; Derouesné, 1995), FNSD is characterized by one or more symptoms of altered voluntary motor or sensory function that are incompatible with recognized neurological or medical conditions (Ozdemir & Sahni, 2019; Hafeza et al., 2020; Lazare, 1981). These symptoms can include paralysis, abnormal movements, non-epileptic seizures, blindness, or sensory loss (Lazare, 1981; Rihab et al., 2022; Stone & Carson, 2015). The symptoms are genuine, not intentionally produced or feigned (Derouesné, 1995; Stone & Carson, 2015), and cause clinically significant distress or impairment in social, occupational, or other important areas of functioning (Dennis & Phipps, 2020; Espay et al., 2018).

The evolution of diagnostic frameworks, particularly in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), has marked a critical paradigm shift in understanding FNSD (Hafeza et al., 2020; van der Feltz & Van Houdenhove, 2014). The term "functional" has gained preference over "psychogenic" as it better reflects a disorder of brain function rather than implying a purely psychological origin (Stone & Carson, 2015; Espay et al., 2018). Crucially, the diagnostic process has moved away from a reliance on identifying psychological stressors as a prerequisite and toward a diagnosis based on positive clinical findings of inconsistency or incongruity with established neurological disease (Espay et al., 2018; Stone & Sharpe, 2020; Stone, 2002). This shift underscores a departure from the historical mind-body dualism that separated "organic" conditions from "functional" ones (Isenberg & Garcia, 2008; Graham, 1967). It is now widely accepted that FNSD represents a genuine disorder of brain function—a "software" problem rather than a "hardware" problem—where the structural integrity of the nervous system is intact, but its function is disordered (Stone & Carson, 2015; Vataja & Leppävuori, 2012).

This chapter aims to provide a comprehensive overview of the biological and neurological mechanisms that are currently understood to underlie FNSD. While the precise pathophysiology remains an area of active investigation, a growing body of evidence points toward specific dysfunctions in neurobiological systems, including neurotransmitter pathways, neural circuits governing motor control and sensory processing, and the brain's capacity for neuroplasticity. The traditional distinction between "organic" and "functional" has obscured the reality that FNSD is a brain disorder, with demonstrable, albeit functional, abnormalities (Isenberg & Garcia, 2008; Roy-Byrne, 2001). By exploring the neurobiological underpinnings of this condition, from cellular mechanisms to large-scale neural networks, we can move toward a more integrated and scientifically grounded understanding. This knowledge is essential not only for refining diagnostic approaches but also for developing targeted, mechanism-based treatments for this common and often disabling disorder (Espay et al., 2018; Stone & Sharpe, 2020).

### Neurobiological Systems

The clinical manifestations of FNSD, which involve profound alterations in motor and sensory function without structural lesions, strongly suggest a primary dysfunction within the central nervous system's regulatory and processing networks (Willis, 2020; Vataja & Leppävuori, 2012). Research points to disturbances in several key neurobiological systems, particularly those involving neurotransmitter modulation, the integration of emotion with motor and sensory processing, and the sense of agency over voluntary actions (Rowe, 2010).

**Neurotransmitter Systems and Neuropharmacology**

While no single neurotransmitter system has been identified as the sole cause of FNSD, evidence from comorbid psychiatric conditions and the effects of psychopharmacological agents provides important clues. FNSD frequently co-occurs with depression and anxiety disorders (Stone & Sharpe, 2020; Goodwin, 2006; Bob et al., 2013), conditions in which abnormalities of the serotonin (5-HT) and norepinephrine (NE) systems are well-documented (Ressler & Nemeroff, 2000; Liu et al., 2019). These monoaminergic systems are crucial for regulating mood, arousal, and cognitive function, and their dysregulation likely contributes to the neuropsychiatric substrate of FNSD (Ressler & Nemeroff, 2000; Kennedy, 2008). Antidepressants, such as selective serotonin reuptake inhibitors (SSRIs), which modulate these systems, are sometimes used in FNSD management, particularly when comorbid mood or anxiety disorders are present (Baldwin et al., 2008), suggesting a potential role for these neurotransmitters in the pathophysiology of FNSD symptoms (Dubovsky & Thomas, 1995). The overlapping efficacy of duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI), in treating depression, neuropathic pain, and stress urinary incontinence suggests a common biochemical basis involving 5-HT and NE in modulating disparate sensory and affective functions (Thor et al., 2007). The physical symptoms common in depression, such as fatigue, pain, and psychomotor changes (Kennedy, 2008; Smith & Blumenthal, 2015), bear a striking resemblance to some presentations of FNSD, further implicating shared monoaminergic pathways (Liu et al., 2019).

The dopaminergic system, critical for motor control, motivation, and reward processing, is another key area of investigation (Liddle, 1993; Hartmann et al., 1993). Dysfunction in dopaminergic pathways is central to movement disorders like Parkinson's disease (Jankovic, 2008), and it is plausible that alterations in these same circuits contribute to functional motor symptoms such as tremor, dystonia, and weakness (Pringsheim et al., 2006). The therapeutic effects of some antipsychotic agents, which block dopamine receptors, can sometimes induce movement disorders (Jones, 1962), highlighting the delicate balance of this system in maintaining normal motor function. Conversely, disturbances in dopaminergic circuits have been linked to agitation and other psychomotor abnormalities seen across various psychiatric disorders (Lindenmayer, 2000), suggesting that dysregulation, rather than simple deficit or excess, may be at play in FNSD.

The GABAergic system, the primary inhibitory neurotransmitter system in the brain, is also implicated, particularly in the context of anxiety and seizure-like phenomena (Hartmann et al., 1993). Benzodiazepines, which enhance GABAergic inhibition, are sometimes used for comorbid anxiety in FNSD (Lindenmayer, 2000), and their effect on motor and cognitive function underscores the importance of inhibitory control in the central nervous system (CNS). The interplay between excitatory (e.g., glutamate) and inhibitory (GABA) systems is fundamental to normal brain function (Hartmann et al., 1993), and a disruption in this balance could plausibly lead to the disinhibition of motor programs or aberrant sensory processing seen in FNSD.

Finally, the cholinergic system, involved in attention, memory, and autonomic function, may also play a role (Pérez-Lloret & Barrantes, 2016). Anticholinergic side effects of some medications can cause cognitive and motor symptoms (Yager, 2015), and dysfunction of central cholinergic pathways is a key feature of some dementias (Dickerson & Sperling, 2007). Given the frequent complaints of cognitive symptoms ("brain fog") in FNSD (Alluri et al., 2020) and the involvement of the autonomic nervous system (Tougas, 2000), alterations in cholinergic neurotransmission warrant further investigation.

**Neural Circuits and Functional Connectivity**

The symptoms of FNSD are increasingly understood as arising from aberrant functional connectivity within large-scale brain networks rather than from a focal lesion (Espay et al., 2018). Key circuits implicated include those that link emotional processing, motor planning, and self-agency. Functional neuroimaging studies have provided crucial insights into these network-level disturbances (Spence, 2006; Rowe, 2010; Saj, 2011).

A recurring finding is the abnormal involvement of prefrontal cortical regions, which are central to executive functions, attention, and the regulation of behavior and emotion (Liddle, 1993; Stuss et al., 1992). Studies of patients with functional paralysis have shown hyperactivation in prefrontal areas, such as the dorsolateral prefrontal cortex (DLPFC) and anterior cingulate cortex (ACC), which appear to exert an inhibitory effect on motor and premotor areas (Rowe, 2010; Saj, 2011; Spence, 2006). This suggests a model where top-down inhibitory control, possibly related to emotional or attentional processes, actively suppresses voluntary motor output (Rowe, 2010). The ACC, in particular, is a critical hub for integrating emotional, cognitive, and motor information and is implicated in monitoring conflict and self-agency (Northoff, 2016; Matisz & Gruber, 2020). Dysfunction in this region could therefore disrupt the normal sense of voluntary control over movement.

The limbic system, including the amygdala and hippocampus, is integral to emotion and memory processing and has strong connections with prefrontal and motor cortices (Engel et al., 1986). Traumatic or stressful life events are recognized as important predisposing and precipitating factors for FNSD (Espay et al., 2018; Bob et al., 2013). It is hypothesized that heightened limbic activity, driven by emotional distress, may aberrantly modulate activity in sensorimotor networks, leading to the generation of functional symptoms (Rowe, 2010). This aligns with the observation that symptoms can vary according to attention and emotional state (Derouesné, 1995).

Furthermore, circuits involving the basal ganglia and cerebellum, which are crucial for the coordination and sequencing of movement, are also implicated (Andreasen, 1999). The basal ganglia, particularly the striatum, are involved in action selection and habit formation (Flanigan & LeClair, 2017). Altered connectivity between the prefrontal cortex and the striatum could lead to inappropriate selection or inhibition of motor programs (Liddle, 1993). Some researchers have noted abnormalities in subcortical structures like the caudate nuclei in syndromes with prominent bodily focus (Spence, 2006). The cerebellum, traditionally associated with motor coordination, is now understood to be part of a cortico-cerebellar-thalamic-cortical circuit (CCTCC) that coordinates both motor and mental activity (Andreasen, 1999). A disruption in this circuitry could lead to a form of "cognitive dysmetria," where the normal coordination between intention, action, and sensory feedback is lost, potentially explaining the incongruent and inconsistent nature of functional symptoms (Andreasen, 1999; Manto, 2012).

Finally, the temporoparietal junction (TPJ) and insula are critical for self-awareness, body ownership, and integrating multisensory information (Spence, 2006; David, 2010). Dysfunction in these regions could underlie sensory symptoms, such as non-anatomic sensory loss, and contribute to a disturbed sense of agency, where movements are perceived as involuntary (Blanco et al., 2022; Gandolfi et al., 2024). This network-based perspective provides a powerful framework for understanding how psychological factors and brain function can interact to produce the complex and often baffling symptoms of FNSD.

### Genetic and Molecular Basis

The investigation into the genetic and molecular underpinnings of Functional Neurological Symptom Disorder is still in its nascent stages, with the available literature offering limited direct evidence. Unlike many other neuropsychiatric conditions, no specific genes or definitive molecular pathways have been robustly identified for FNSD itself. However, insights can be gleaned by examining the genetic landscape of frequently comorbid conditions and by considering theoretical models of neurobiological vulnerability.

**Heritability and Familial Factors**

Clinical observations have long suggested a potential familial component to FNSD, though this is difficult to disentangle from shared environmental and psychosocial factors (Vandvik & Skjeldal, 1994). Families may share patterns of illness behavior, coping styles, or exposure to stressors, which could contribute to the apparent clustering of functional symptoms (Stone et al., 2005). The presence of a "model" for the child's symptoms within the family has been noted in pediatric cases, suggesting a role for learning and social modeling in symptom expression (Agarwal et al., 2019; Vandvik & Skjeldal, 1994). However, this does not preclude an underlying shared genetic vulnerability.

The high rates of comorbidity with disorders known to have a significant genetic component, such as major depressive disorder, anxiety disorders, and bipolar disorder, provide an indirect line of evidence (Stone & Sharpe, 2020; Goodwin, 2006; Ghaemi, 2018). Genetic factors are known to play a role in predisposing individuals to these conditions (Ferrier, 1993), and it is plausible that some of this genetic liability may also confer a risk for developing FNSD, perhaps by influencing stress reactivity, emotional regulation, or neuro-immune pathways (Anisman & Hayley, 2012). For instance, genetic predispositions are thought to influence the development of central neurotransmitter system dysfunctions, such as those involving serotonin and norepinephrine, which are implicated in both mood disorders and the modulation of somatic symptoms (Ressler & Nemeroff, 2000; Liu et al., 2019). The concept of a "general neurotic syndrome" suggests that a shared, heritable personality predisposition, such as high neuroticism, may underlie the co-occurrence of various neurotic syndromes, including anxiety, depression, and potentially somatoform presentations (Andrews et al., 1990).

**Candidate Genes and Molecular Mechanisms**

Direct research into candidate genes for FNSD is sparse in the provided literature. However, we can hypothesize potential avenues based on the neurobiological systems implicated in the disorder. Genes involved in the regulation of the hypothalamic-pituitary-adrenal (HPA) axis, the primary neuroendocrine stress response system, are strong candidates for investigation (Ventriglio et al., 2015). Chronic stress is a significant risk factor for FNSD (Espay et al., 2018), and genetic variations affecting cortisol regulation or glucocorticoid receptor sensitivity could modulate an individual's vulnerability to developing symptoms following a stressor (Ventriglio et al., 2015; Beszczyńska, 2007). Neuroendocrine abnormalities, particularly related to stress-induced hypercortisolism, are common in depression and may trigger other dysfunctions (von Zerssen et al., 1986).

Genes related to monoamine neurotransmitter systems (serotonin, norepinephrine, dopamine) are also of significant interest (Liu et al., 2019). Polymorphisms in genes for serotonin transporters (SERT), dopamine receptors, or enzymes like catechol-O-methyltransferase (COMT) have been extensively studied in mood, anxiety, and psychotic disorders (Dubovsky & Thomas, 1995; Ressler & Nemeroff, 2000). These same genetic variations could influence the neurochemical environment in brain circuits relevant to FNSD, such as the prefrontal-limbic-striatal loops that govern emotion, motivation, and motor control (Liddle, 1993; Hartmann et al., 1993).

Another emerging area of interest is the role of neuro-immune interactions (Arushanian & Beĭer, 2004). Stress and psychopathology can influence immune function, and conversely, immune activation and inflammation can trigger psychiatric symptoms (Anisman & Hayley, 2012; Glassford, 2017). This "sickness behavior"—characterized by fatigue, anhedonia, and psychomotor slowing—is mediated by cytokines and shares features with both depression and FNSD (Hennessy et al., 2001; Tanaka et al., 2021). Genetic factors that regulate inflammatory responses could therefore contribute to an individual's susceptibility. For example, some researchers have proposed that conditions like chronic fatigue syndrome, which overlaps significantly with FNSD, may involve sustained glial activation, oxidative stress, and neuroinflammation (Glassford, 2017; Pigarova et al., 2010).

In summary, while the specific genetic and molecular basis of FNSD remains largely uncharted territory, the disorder's strong association with other heritable psychiatric conditions points toward a shared diathesis. Future research will likely focus on genes modulating stress response systems, monoaminergic neurotransmission, and neuro-immune pathways to elucidate the biological vulnerabilities that, in concert with environmental and psychological factors, give rise to functional neurological symptoms.

### Brain Structure and Function

The conceptualization of FNSD as a disorder of brain function, rather than structure, is a cornerstone of its modern understanding (Stone & Carson, 2015; Vataja & Leppävuori, 2012). While conventional structural neuroimaging techniques like computed tomography (CT) and magnetic resonance imaging (MRI) typically reveal no identifiable pathology that can explain the symptoms, functional neuroimaging has begun to uncover the dynamic neural correlates of this complex condition (Spence, 2006; Rowe, 2010; Saj, 2011). These findings provide objective evidence of altered brain activity, supporting the view that FNSD is a genuine neuropsychiatric disorder rooted in aberrant brain processes (Roy-Byrne, 2001; Espay et al., 2018).

**Structural Neuroimaging Findings**

By definition, FNSD lacks a corresponding structural lesion that would be expected to cause the presenting neurological symptoms (Lazare, 1981; Derouesné, 1995). Neurological examinations are performed to exclude pathology rather than to elucidate dysfunction (Spence, 2006). The diagnosis often hinges on the incompatibility of symptoms with known anatomical pathways and neurological mechanisms (Stone & Sharpe, 2020). For instance, functional sensory loss may not conform to dermatomal distributions (Derouesné, 1995; Egloff et al., 2013), and functional weakness may present in patterns inconsistent with upper or lower motor neuron lesions (Stone, 2002).

However, the absence of explanatory lesions on standard clinical imaging does not mean that subtle structural brain alterations are entirely absent. Some studies using advanced morphometric techniques have suggested subtle gray matter changes in certain brain regions, although findings have been inconsistent and their significance is debated (Valet et al., 2007). For instance, in somatoform pain disorder, a related condition, subtle gray matter alterations have been observed in pain-processing brain structures (Valet et al., 2007). It remains unclear whether such changes are a cause or consequence of the chronic disorder, potentially related to disuse, altered sensory input, or chronic stress (Spence, 2006). Importantly, organic brain disease can sometimes facilitate the development of conversion symptoms (Roy-Byrne, 2001), and the presence of a neurological disease does not exclude a coexisting functional disorder (Stone, 2002; Roobol et al., 2019). This highlights the complexity of diagnosis and the need to rely on positive clinical signs rather than solely on the absence of imaging findings (Espay et al., 2018).

**Functional Neuroimaging Findings**

Functional neuroimaging techniques, such as functional magnetic resonance imaging (fMRI) and positron emission tomography (PET), have been instrumental in moving the field beyond a diagnosis of exclusion (Gracely, 2003). These methods have revealed consistent patterns of brain activity associated with the experience and inhibition of functional symptoms.

A central theme emerging from this research is a pattern of altered top-down regulation, particularly involving prefrontal and limbic structures impacting sensorimotor cortex activity (Rowe, 2010; Saj, 2011). In studies of patients with functional paralysis or weakness, tasks requiring movement of the affected limb are often associated with hypoactivation in primary motor and supplementary motor areas (SMA), consistent with the failure to execute movement (Espay et al., 2018). Concurrently, these studies often show hyperactivation in prefrontal regions, including the dorsolateral prefrontal cortex (DLPFC), ventrolateral prefrontal cortex (VLPFC), and anterior cingulate cortex (ACC), as well as in limbic areas like the amygdala (Spence, 2006; Rowe, 2010). This pattern suggests that an active, though not consciously willed, inhibition of motor cortex is occurring, driven by frontal executive and emotional-regulatory networks (Saj, 2011; Oakley et al., 2003). This provides a neurobiological correlate for the idea that psychological factors, such as emotional conflict or stress, can translate into motor symptoms (Willis, 2020).

Studies focusing on the sense of agency—the feeling of being in control of one's own actions—have implicated the temporoparietal junction (TPJ) and precuneus. In FNSD, there appears to be a disconnection between the intention to move and the subjective experience of that movement being self-generated (Gandolfi et al., 2024). Altered activity in these regions, which are critical for self-awareness and distinguishing self from other, may explain why patients perceive their symptoms as involuntary and alien (David, 2010).

Functional sensory loss, such as hysterical anesthesia, has also been investigated. In these cases, initial sensory processing in primary somatosensory cortex may be intact, but further processing in higher-order association areas is disrupted (Gracely, 2003). This suggests that the sensory information is received by the brain but is not integrated into conscious awareness, again pointing to a top-down modulatory mechanism that gates sensory perception (Spence, 2006).

These functional imaging findings are crucial because they provide objective evidence of brain dysfunction that correlates with the patient's subjective experience. They help to validate the patient's symptoms as "real" and not "all in the mind" in a pejorative sense (Gracely, 2003), shifting the conceptualization of FNSD from a purely psychological issue to a neuropsychiatric one. This neurobiological evidence is also instrumental in explaining the diagnosis to patients, which is a critical first step in effective management (Stone et al., 2005; Stone & Edwards, 2012). It helps frame the disorder as a potentially reversible problem with brain network function, akin to a software glitch, which can be retrained through therapies like physiotherapy and cognitive behavioral therapy (Espay et al., 2018).

### Developmental Neurobiology

The presentation and etiology of Functional Neurological Symptom Disorder are significantly influenced by developmental factors, with distinct patterns emerging across the lifespan, particularly during childhood and adolescence. This period is marked by profound neurobiological maturation and heightened sensitivity to psychosocial stressors, creating a unique context for the development of FNSD (Vandvik & Skjeldal, 1994; Sunde et al., 2020).

**Onset and Prevalence in Youth**

FNSD is more common in adolescence than in early childhood and is rarely seen before the age of seven (Vandvik & Skjeldal, 1994; Agarwal et al., 2019). The prevalence increases during the teenage years, with a notable preponderance in girls (Vandvik & Skjeldal, 1994). This developmental timing suggests that the neurobiological and psychosocial changes inherent to adolescence—such as hormonal shifts, the maturation of prefrontal-limbic circuits involved in emotion regulation, and increasing social and academic pressures—may create a period of vulnerability (Sunde et al., 2020; Rihab et al., 2022). The developing brain's capacity for neuroplasticity is immense, but this same malleability may also render it susceptible to maladaptive learning patterns in response to stress or trauma (Stone et al., 2005).

**The Role of Stress and Trauma in Neurodevelopment**

Exposure to psychological stress or trauma is a well-established risk factor for FNSD at all ages, but it may be particularly impactful during critical periods of neurodevelopment (Copeland-Linder et al., 2017; Bob et al., 2013). Early life stress, including physical or sexual abuse, neglect, or significant family conflict, can have lasting effects on the development of the hypothalamic-pituitary-adrenal (HPA) axis and central neurotransmitter systems that regulate stress and emotion (Ventriglio et al., 2015; Beszczyńska, 2007). Such experiences can lead to a state of heightened physiological arousal and altered connectivity in brain networks linking the amygdala, hippocampus, and prefrontal cortex, which are central to fear processing, memory, and executive control (Engel et al., 1986). This neurobiological sensitization may lower the threshold for developing FNSD symptoms in response to subsequent, even minor, stressors (Bob et al., 2013). In pediatric FNSD, stressors are often identifiable and temporally associated with symptom onset, and may include academic difficulties, peer relationship problems, family conflict, or frightening experiences (Agarwal et al., 2019; Sunde et al., 2020).

The brain's response to trauma can involve dissociative processes, which are disruptions in the normally integrated functions of consciousness, memory, and identity (Maldonado & Spiegel, 2015; Nijenhuis, 2022). Dissociation is thought to be a defense mechanism that allows the individual to disconnect from overwhelming experiences (Mut, Pălădoiu, & Stănescu, 2021). The high co-occurrence of dissociative symptoms and disorders with FNSD suggests shared neurobiological mechanisms (Blanco et al., 2022). From a developmental perspective, the capacity for dissociation may be more pronounced in children and adolescents, whose sense of self and integrated cognitive functions are still maturing (Agarwal et al., 2019). Neurobiologically, this may relate to the incomplete maturation of prefrontal cortical control over limbic and associative parietal regions involved in self-awareness and bodily representation (David, 2010).

**Symptom Modeling and Social Learning**

Developmental context also influences the specific presentation of functional symptoms through processes of social learning and symptom modeling (Vandvik & Skjeldal, 1994). Children and adolescents may unconsciously model their symptoms on those of family members, peers, or even figures from media who have a physical illness (Stone et al., 2005). This is not a conscious imitation but rather a process where a culturally or personally relevant illness script provides a template for the expression of distress (Derouesné, 1995). For instance, a child in a family with a high degree of anxiety about health problems may be more likely to develop somatic symptoms as a manifestation of their own distress (Vandvik & Skjeldal, 1994). This process is likely mediated by brain systems involved in observation, imitation, and social cognition, including mirror neuron systems and theory of mind networks (Green & Horan, 2010).

The developing brain's interpretation of bodily sensations is also crucial. The individual's conceptualization of a condition can shape the symptoms, which often do not conform to known neurological mechanisms but rather follow the patient's lay understanding of illness (Derouesné, 1995). This is particularly evident in pediatric FNSD, where symptoms can be variable and reflect the child's developmental level of understanding about their body and disease (Sunde et al., 2020). The interaction between a child's temperament, personality (e.g., a conscientious attitude), and family dynamics (e.g., high expectations) creates a specific psychosocial environment that can either buffer against or promote the development of functional symptoms in response to biological vulnerability and external stressors (Vandvik & Skjeldal, 1994). Understanding these developmental neurobiological pathways is critical for tailoring assessments and interventions for young people with FNSD.

### Treatment Mechanisms

Understanding the biological basis of FNSD not only refines its diagnosis but also provides a crucial framework for interpreting how various treatments exert their effects. Effective interventions for FNSD, which primarily include specialized physical and psychological therapies, are thought to work by targeting the maladaptive neuroplastic changes and aberrant network functions that underlie the disorder (Espay et al., 2018; Stone & Sharpe, 2020).

**Neuroplasticity and Physical Rehabilitation**

Physical therapies, such as physiotherapy, are a cornerstone of treatment for functional motor symptoms like weakness, tremor, and gait disorders (Stone & Sharpe, 2020; Serranová, 2022). The biological rationale for their effectiveness lies in the principle of neuroplasticity—the brain's ability to reorganize its structure and function in response to experience and training (Møller, 2001). In FNSD, it is hypothesized that abnormal patterns of motor control have become learned and automated, maintained by factors such as abnormal attentional focus on the body and maladaptive illness beliefs (Stone et al., 2005).

Specialized physiotherapy for FNSD aims to reverse these maladaptive patterns by retraining normal movement (Gandolfi et al., 2024). This is often achieved by using techniques that divert attention away from the act of moving, thereby facilitating the automatic motor programs that remain intact (Stone, 2024). For example, a therapist might encourage a patient with functional leg weakness to focus on kicking a ball rather than on the mechanics of leg extension, tapping into preserved, goal-directed motor circuits (Stone & Edwards, 2012). This process is thought to promote the re-establishment of normal functional connectivity between prefrontal/attentional networks and motor execution areas like the SMA and primary motor cortex (Rowe, 2010). By providing positive feedback and demonstrating to the patient that normal movement is possible (e.g., by eliciting Hoover's sign in a therapeutic context), therapists can challenge maladaptive illness expectations and help restore the patient's sense of agency over their body (Stone & Edwards, 2012; Stone, 2024). This therapeutic process essentially involves guided neuroplasticity, helping the brain to "unlearn" the dysfunctional motor habits and "relearn" healthy ones (Dimitrijević et al., 2011).

**Cognitive and Attentional Modulation through Psychotherapy**

Psychological treatments, particularly cognitive behavioral therapy (CBT), have shown efficacy for FNSD, especially for non-epileptic attacks and cases with significant comorbid anxiety or depression (Kumari et al., 2025; Nicholson et al., 2019). The neurobiological mechanism of CBT is thought to involve strengthening top-down cognitive control and modifying the attentional and emotional processes that trigger and perpetuate symptoms (Stone et al., 2005).

CBT helps patients identify and challenge dysfunctional thoughts and beliefs about their symptoms (e.g., catastrophic interpretations of bodily sensations) (Lemogne et al., 2019). This cognitive restructuring is believed to modulate activity in prefrontal cortical regions responsible for executive function and emotional regulation, which in turn can dampen the hyperactive limbic responses (e.g., in the amygdala) that may drive symptoms (Rowe, 2010; Sahakian & Morein-Zamir, 2011). By teaching patients to shift their attentional focus away from their body and to reduce hypervigilance for symptoms, CBT directly targets a core proposed mechanism of FNSD (Espay et al., 2018). This re-training of attentional networks can help break the cycle where excessive body-focused attention amplifies normal bodily sensations into distressing symptoms (Barsky, 1979). For dissociative or non-epileptic seizures, CBT helps patients recognize early warning signs and apply behavioral techniques to prevent seizure escalation, thereby restoring a sense of control and modifying the learned neural pathways that lead to the attacks (Kumari et al., 2025).

**Neuromodulation and Pharmacotherapy**

While there are no specific pharmacological agents approved for FNSD, medications are often used to treat common comorbid conditions like depression and anxiety (Stone & Sharpe, 2020). Antidepressants that modulate serotonergic and noradrenergic systems can alleviate mood and anxiety symptoms, which may indirectly improve functional symptoms by reducing the overall level of emotional and physiological arousal that contributes to them (Ressler & Nemeroff, 2000; Liu et al., 2019). By stabilizing limbic system activity, these medications may reduce the aberrant influence of emotion on motor and sensory networks (Ferrier, 1993).

More direct approaches to altering brain circuit function include non-invasive brain stimulation techniques like transcranial magnetic stimulation (TMS). While still largely experimental for FNSD, TMS has been explored as a potential therapeutic tool (Feinstein, 2008; Koops et al., 2017). For instance, inhibitory TMS applied over hyperactive prefrontal regions or excitatory TMS over hypoactive motor areas could theoretically help to rebalance the dysfunctional network activity identified in functional imaging studies (Feinstein, 2008). The reported spectacular recovery of a patient with psychogenic aphonia after motor cortex TMS highlights the potential for such techniques to directly modulate the neural circuits involved in symptom production (Feinstein, 2008). These approaches offer a promising avenue for future treatments that are directly informed by our evolving neurobiological understanding of FNSD.

### Future Directions

The past two decades have witnessed a significant transformation in the conceptualization of FNSD, moving from a largely psychodynamic framework to a neurobiological one (Stone & Carson, 2015; Espay et al., 2018). However, our understanding of the underlying mechanisms remains incomplete, and many critical questions persist. Future research must build upon the current foundation to refine diagnostic tools, elucidate pathophysiology, and develop more effective, mechanism-based treatments.

A primary goal for the field is the development and validation of robust biological markers. While functional neuroimaging has provided invaluable insights into network dysfunction in FNSD (Rowe, 2010; Spence, 2006; Saj, 2011), these findings are largely based on group-level analyses and are not yet applicable as diagnostic tools for individual patients. Future research should focus on identifying reliable neuroimaging or electrophysiological "fingerprints" of FNSD that can aid in diagnosis and differentiate it from both organic neurological disorders and malingering (Miyawaki, 2001; Valls-Solé, 2016). Techniques that probe functional and effective connectivity, perhaps in response to specific motor or cognitive challenges, may hold particular promise (Gandolfi et al., 2024). For example, investigating the coupling of cerebral blood flow and functional connectivity could reveal specific neurovascular alterations in FNSD (Chen et al., 2022).

The role of genetic and molecular factors is a significant blind spot in the current literature. Large-scale genetic studies, such as genome-wide association studies (GWAS), are urgently needed to identify potential susceptibility genes for FNSD. Given the high comorbidity with mood and anxiety disorders (Stone & Sharpe, 2020), research should explore shared genetic vulnerabilities, particularly in genes related to stress response (HPA axis), monoaminergic neurotransmission, and neuro-immune pathways (Ventriglio et al., 2015; Liu et al., 2019). Epigenetic studies could also illuminate how environmental factors, such as early life trauma, modify gene expression to increase risk for FNSD (Ventriglio et al., 2015).

Longitudinal studies are critical to understanding the trajectory of FNSD. Much of the current research is cross-sectional, providing only a snapshot of brain function. Prospective studies that follow high-risk individuals (e.g., those with recent trauma or a new diagnosis of a comorbid psychiatric disorder) could help identify the neurobiological changes that precede the onset of functional symptoms. Similarly, tracking patients over time, from diagnosis through treatment and recovery, would allow researchers to link changes in brain function and structure to clinical outcomes (Espay et al., 2018). This would help clarify whether observed brain alterations are state or trait markers and whether they are normalized by successful treatment.

Further research is also needed to understand the heterogeneity of FNSD. The disorder encompasses a wide range of symptoms, from motor to sensory to cognitive (Alluri et al., 2020; Stone et al., 2015). It is unlikely that a single neurobiological model can account for this diversity. Future studies should aim to identify biological subtypes of FNSD, potentially linking different symptom profiles (e.g., tremor vs. weakness vs. non-epileptic seizures) to distinct patterns of neural network dysfunction. This would be a crucial step toward personalized medicine, allowing for the tailoring of treatments to the specific neurobiological profile of the patient (Espay et al., 2018).

Finally, the development and testing of novel, mechanism-based treatments is a key priority. While physiotherapy and CBT have shown promise, their efficacy needs to be confirmed in larger, more rigorous randomized controlled trials (Nicholson et al., 2019). The insights from functional neuroimaging should be used to guide the development of new therapies. For example, real-time fMRI neurofeedback could be used to train patients to voluntarily modulate activity in the specific brain regions, such as the prefrontal cortex or SMA, that are dysregulated in their condition. Further investigation into non-invasive brain stimulation techniques like TMS and transcranial direct current stimulation (tDCS) is also warranted to determine if they can directly rebalance the pathological network dynamics in FNSD (Koops et al., 2017; Feinstein, 2008). As our understanding of the brain-behavior relationships in FNSD deepens, so too will our ability to design rational and effective interventions.

### Conclusion

Functional Neurological Symptom Disorder, or Conversion Disorder, represents a profound and disabling condition that has long challenged the boundaries of medicine and psychiatry. The historical tendency to view its symptoms through a lens of mind-body dualism has often led to stigmatization and therapeutic nihilism (Isenberg & Garcia, 2008; Graham, 1967). However, the evidence synthesized in this chapter illustrates a decisive shift toward a modern, integrated neurobiological framework. FNSD is no longer a diagnosis of exclusion based on the absence of organic disease, but rather a rule-in diagnosis based on positive clinical signs that reflect a genuine, albeit functional, disturbance of the nervous system (Espay et al., 2018; Stone & Sharpe, 2020).

The biological basis of FNSD is increasingly understood as a disorder of brain networks. While structural integrity is preserved, functional connectivity is disrupted, particularly within circuits that integrate emotion, attention, self-agency, and sensorimotor control (Rowe, 2010; Saj, 2011). Key findings point to aberrant top-down regulation from prefrontal and limbic regions that inhibit or distort motor and sensory processing, providing a neural substrate for the conversion of psychological distress into physical symptoms (Spence, 2006). This model is supported by functional neuroimaging studies that reveal hypoactivation in motor execution areas alongside hyperactivation in frontal-limbic control regions during symptom states (Rowe, 2010).

Neurotransmitter systems, especially the monoaminergic pathways involving serotonin and norepinephrine, are implicated through the high comorbidity of FNSD with mood and anxiety disorders and the partial efficacy of medications targeting these systems (Liu et al., 2019; Ressler & Nemeroff, 2000). Developmental factors, particularly exposure to stress and trauma during critical neurodevelopmental windows, appear to sensitize these neurobiological systems, creating a vulnerability that can be triggered later in life (Bob et al., 2013; Vandvik & Skjeldal, 1994).

This neurobiological understanding provides a rational basis for current therapeutic approaches. Physiotherapy and cognitive behavioral therapy are not merely supportive measures; they are active interventions designed to leverage neuroplasticity to retrain maladaptive neural pathways and restore normal brain function (Stone & Sharpe, 2020; Gandolfi et al., 2024). By targeting dysfunctional attentional processes, illness beliefs, and automated motor programs, these therapies help patients regain a sense of control and reverse the functional impairments.

In conclusion, FNSD is a neuropsychiatric disorder par excellence, demanding a holistic, biopsychosocial approach that acknowledges the intricate interplay between the brain, mind, and body (Stone et al., 2005). While much remains to be discovered about its precise molecular and genetic underpinnings, the current evidence firmly establishes FNSD as a disorder of brain function. Continued research into its neural mechanisms is not only essential for de-stigmatizing the condition but is also the most promising path toward developing more effective and targeted treatments for the many individuals who suffer from its debilitating symptoms.

## References

1. Aasvik, J. K., Stiles, T. C., Woodhouse, A., Borchgrevink, P., & Landrø, N. I. (2017). The Effect of Insomnia on Neuropsychological Functioning in Patients with Comorbid Symptoms of Pain, Fatigue, and Mood Disorders. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acx040
2. Abbasi, S., Velickovic, M., & Brin, M. F. (2001). MYOCLONUS. The Neurologist. https://doi.org/10.1097/00127893-200105000-00004
3. Abdo, C. H. N. (2017). Sexualidade e doenças reumáticas. Revista Paulista de Reumatologia. https://doi.org/10.46833/reumatologiasp.2017.16.3.6-12
4. Adler, G. (2006). Diagnostik der Demenz. Notfall & Hausarztmedizin (Notfallmedizin). https://doi.org/10.1055/s-2006-959110
5. Agarwal, V., Sitholey, P., & Srivastava, C. (2019). Clinical practice guidelines for the management of dissociative disorders in children and adolescents. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_493_18
6. Agronin, M. (2015). Somatic Symptom and Related Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370054.ds13
7. Agudelo, D., Spielberger, C. D., & Buela‐Casal, G. (2007). La depresión: ¿un trastorno dimensional o categorial?. Salud Mental.
8. Albin, C. S. W., & Kimchi, E. Y. (2024). The Framing and Scope of Altered Mental Status and Delirium. Seminars in Neurology. https://doi.org/10.1055/s-0044-1790198
9. Albrecht, S., Leineweber, C., Ojajärvi, A., Oksanen, T., Kecklund, G., & Härmä, M. (2020). Association of work-time control with sickness absence due to musculoskeletal and mental disorders: An occupational cohort study. Journal of Occupational Health. https://doi.org/10.1002/1348-9585.12181
10. Alluri, P. R., Solit, J., Leveroni, C. L., Goldberg, K. J., Vehar, J. V., Pollak, L., Colvin, M. K., & Perez, D. L. (2020). Cognitive Complaints in Motor Functional Neurological (Conversion) Disorders: A Focused Review and Clinical Perspective. Cognitive and Behavioral Neurology. https://doi.org/10.1097/wnn.0000000000000218
11. Almondes, K. M. D., Azevedo, J. P. D., Santos, M. B. D., & Soares, W. B. (2021). Case Report in the Brazilian Context: Cognitive and Behavioral Changes Following an Electric Injury. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2021.684817
12. Amoah, C., Heck, D. E., & Kim, H. D. (2022). Sensing metabolomics landscape unfold molecular connectivity between mental illness and drug abuse. GSC Biological and Pharmaceutical Sciences. https://doi.org/10.30574/gscbps.2022.18.3.0102
13. Andreasen, N. C. (1999). A Unitary Model of Schizophrenia. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.56.9.781
14. Andrews, G., Stewart, G., Morris‐Yates, A., Holt, P. E., & Henderson, S. (1990). Evidence for a General Neurotic Syndrome. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.157.1.6
15. Anestya, N., Saputra, G. N., Alam, A., & Yollamanda, P. (2022). Manifestasi Neurooftalmologi pada Penyakit Parkinson dan Gangguan Gerak Lainnya. Cermin Dunia Kedokteran. https://doi.org/10.55175/cdk.v49i3.205
16. Anisman, H., & Hayley, S. (2012). Illness comorbidity as a biomarker?. Journal of Psychiatry and Neuroscience. https://doi.org/10.1503/jpn.120092
17. Annoni, J., Schluep, M., & Calabrese, P. (2008). Are the Diagnosis and Treatment of Neuropsychiatric Comorbidity in Multiple Sclerosis Still in Their Infancy?. touchREVIEWS in Neurology. https://doi.org/10.17925/usn.2008.04.01.19
18. Antonis, T. (2021). Memory, Attention and Language Disorders in Craniocerebral Injury. https://doi.org/10.36648/2472-5048.21.6.002
19. Arandjelovic, D., Misic, P., Serafimovic, S., & Petrovic, M. (2010). P01-366 - Psychiatric Syndromes and Disorders in Older Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(10)70574-5
20. Arango, C., Kirkpatrick, B., & Buchanan, R. W. (2000). Neurological Signs and the Heterogeneity of Schizophrenia. American Journal of Psychiatry. https://doi.org/10.1176/appi.ajp.157.4.560
21. Araújo, R. C. B., Gomes, R. M., & Barbosa, M. U. F. (2017). A IMPORTÂNCIA DO BOBATH EM PACIENTES COM PARALISIA CEREBRAL.
22. Arenson, C., Busby‐Whitehead, J., Brummel‐Smith, K., O’Brien, J. G., Palmer, M. H., & Reichel, W. (2010). Evaluation and Management of Dementia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511575952.017
23. Arias-Falcón, Y., Reyes-Castellano, A. J., & Pequeño-Rondón, M. M. (2020). Síndrome del niño maltratado. Revista electrónica "Dr. Zoilo E. Marinello Vidaurreta".
24. Arnold, L. E. (1993). Clinical Pharmacological Issues in Treating Psychiatric Disorders of Patients with Mental Retardation. Annals of Clinical Psychiatry. https://doi.org/10.3109/10401239309148982
25. Atzeni, F., Altomonte, L., Leardini, G., Marsico, A., Gorla, R., Casale, R., Cassisi, G., Stisi, S., Salaffi, F., Marinangeli, F., Giamberardino, M., Franco, M. D., Biasi, G., Arioli, G., Alciati, A., Ceccherelli, F., Bazzichi, L., Carignola, R., Cazzola, M., ... Sarzi‐Puttini, P. (2011). Fibromyalgia syndrome: preventive, social and economic aspects. Reumatismo. https://doi.org/10.4081/reumatismo.2008.1s.70
26. Autor, S. (2002). CÁPSULAS PARA LA VIDA.- ANSIEDAD. Gaceta UNAM (2000-2009).
27. Autora, M. C. D. T., & Principal, C. I. Y. D. R. P. T. (2017). Funcionamiento cognitivo y alteraciones pragmáticas en pacientes con Esclerosis Múltiple.
28. Axelrod, B. N. (2008). Fabrication of psychiatric symptoms: Somatoform and psychotic disorders. Psychology Press eBooks. https://doi.org/10.4324/9780203890042-23
29. Ayazöz, Y., Aşoğlu, M., & ÇADIRCI, D. (2020). First Manic Attack After Electric Shock: Case Report. Harran Üniversitesi Tıp Fakültesi Dergisi. https://doi.org/10.35440/hutfd.701306
30. Bach, A. S., Oertel, W. H., & Bach, J.-P. (2010). Kognitive Defizite als Komorbidität neurologischer Erkrankungen. Nervenheilkunde. https://doi.org/10.1055/s-0038-1628839
31. Bach, F. W., Finnerup, N. S. B., & Jensen, T. S. (2006). [Neuropathic pain].. PubMed.
32. Bailón, M. R., Mosquera, M. T., Pérez, R. R., & Montoro, M. A. (2012). Mutismo Acinético: revisión, propuesta de un protocolo neuropsicológico para el diagnóstico diferencial y su aplicación a un caso.. Anales de Psicología. https://doi.org/10.6018/analesps.28.3.124731
33. Baldwin, D. S., Ajel, K., & Garner, M. (2008). Anxiety disorders. Medicine. https://doi.org/10.1016/j.mpmed.2008.05.002
34. Ball, H. A., McWhirter, L., Ballard, C., Bhome, R., Blackburn, D., Edwards, M. J., Fleming, S. M., Fox, N. C., Howard, R., Huntley, J., Isaacs, J. D., Larner, A. J., Nicholson, T. R., Pennington, C., Poole, N., Price, G., Price, J. P., Reuber, M., Ritchie, C., ... Carson, A. (2020). Functional cognitive disorder: dementia’s blind spot. Brain. https://doi.org/10.1093/brain/awaa224
35. Baloh, R. W., & Honrubia, V. (2001). Toxic/Metabolic Disorders. https://doi.org/10.1093/oso/9780195139822.003.0016
36. Bangwal, R., Bisht, S., Saklani, S., Garg, S., & Dhayani, M. (2020). Psychotic Disorders, Definition, Sign and Symptoms, Antipsychotic Drugs, Mechanism of Action, Pharmacokinetics &amp; Pharmacodynamics with Side Effects &amp; Adverse Drug Reactions: Updated Systematic Review Article. Journal of Drug Delivery and Therapeutics. https://doi.org/10.22270/jddt.v10i1.3865
37. Bannister, S. R. (1992). Parkinsonism and movement disorders. https://doi.org/10.1093/oso/9780192619891.003.0017
38. Barker, R. A., & Redfern, C. (2019). Parkinson’s Disease, Religious Belief and Spirituality. Cambridge University Press eBooks. https://doi.org/10.1017/9781316014165.011
39. Barrera, L. M. E. (2020). Una terapia con carga positiva. Universitas Científica.
40. Barrio, A. G. D. (2018). Intervención Psicoterapéutica Integrada y Transdiagnóstica en los Trastornos de la Conducta Alimentaria. Revista de Psicoterapia. https://doi.org/10.33898/rdp.v29i110.248
41. Barsky, A. J. (1979). Patients Who Amplify Bodily Sensations. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-91-1-63
42. Baum, R., & Campo, J. V. (2022). Medically Unexplained Symptoms. Pediatric Care Online. https://doi.org/10.1542/aap.ppcqr.396501
43. Beaudreau, S. A., & Gould, C. E. (2015). Definition of Mental Disorder. The Encyclopedia of Adulthood and Aging. https://doi.org/10.1002/9781118521373.wbeaa190
44. Becerril‐Villanueva, E., Gutiérrez, M. E. H., Camacho, I. G., García, L. Á., Pérez‐Tapia, S. M., & Romero, L. P. (2012). Los efectos conductuales modulados por las citocinas. Salud Mental.
45. Begué, N. M., Cobos, E., Quiñones, S. M., & Ginebreda, J. A. (2011). Alteraciones morfologícas del disco óptico. Annals d'oftalmologia: òrgan de les Societats d'Oftalmologia de Catalunya, Valencia i Balears.
46. Bejenaru, A., & Ellison, J. M. (2020). Medicolegal Implications of Mild Neurocognitive Disorder. Journal of Geriatric Psychiatry and Neurology. https://doi.org/10.1177/0891988720957092
47. Belagaje, S., & Bonomo, J. (2012). A Person with Factitious Disorder Presenting with Acute Stroke-Like Symptoms and Receiving Thrombolytic Therapy Twice. Journal of Clinical Case Reports. https://doi.org/10.4172/2165-7920.1000138
48. Beletsky, V., & Mirsattari, S. M. (2011). Epilepsy, Mental Health Disorder, or Both?. Epilepsy Research and Treatment. https://doi.org/10.1155/2012/163731
49. Bellman, V., Chinthalapally, A., Johnston, E., Russell, N. D., Bruce, J. M., & Saleem, S. (2022). Malingering of Psychotic Symptoms in Psychiatric Settings: Theoretical Aspects and Clinical Considerations. Psychiatry Journal. https://doi.org/10.1155/2022/3884317
50. Bento, D. B., & Rigo, F. R. (2020). BENEFÍCIOS DA MELATONINA NA ENXAQUECA. Inova Saúde. https://doi.org/10.18616/inova.v9i2.3738
51. Berk, M., Post, R. M., Ratheesh, A., Gliddon, E., Singh, A., Vieta, E., Carvalho, A. F., Ashton, M. M., Berk, L., Cotton, S., McGorry, P. D., Fernandes, B. S., Yatham, L. N., & Dodd, S. (2017). Staging in bipolar disorder: from theoretical framework to clinical utility. World Psychiatry. https://doi.org/10.1002/wps.20441
52. Berlot, R., Rothwell, J. C., Bhatia, K. P., & Kojović, M. (2020). Variability of Movement Disorders: The Influence of Sensation, Action, Cognition, and Emotions. Movement Disorders. https://doi.org/10.1002/mds.28415
53. Bernáldez, M. I. (2015). Valoración médico legal de la fibromialgia en el campo de la patología laboral. CADERNOS IBERO-AMERICANOS DE DIREITO SANITÁRIO. https://doi.org/10.17566/ciads.v4i1.189
54. Bersani, F. S., Mellon, S. H., Reus, V. I., & Wolkowitz, O. M. (2019). Accelerated aging in serious mental disorders. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000525
55. Bertelli, M. O., Groef, J. D., & Rondini, E. (2019). Phenomenological Psychopathology of Neurodiversity. https://doi.org/10.1093/oxfordhb/9780198803157.013.100
56. Bertodo, T. D. S., Gross, M. S., & Maldaner, E. B. (2018). TRANSTORNOS BIPOLAR E DEPRESSIVO: UMA REVISÃO DOS ASPECTOS CONCEITUAIS.
57. Beszczyńska, B. (2007). [Molecular basis of stress-evoked psychiatric disturbances].. PubMed.
58. Binder, L. M., & Campbell, K. A. (2004). Medically Unexplained Symptoms and Neuropsychological Assessment. Journal of Clinical and Experimental Neuropsychology. https://doi.org/10.1080/13803390490510095
59. Binder, L. M., Spector, J. J., & Youngjohn, J. R. (2012). Psychogenic Stuttering and Other Acquired Nonorganic Speech and Language Abnormalities. Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acs051
60. Binder, M. R. (2022). Focused Neuroregulation in the Treatment and Prevention of Mental and Physical Illness. American Journal of Clinical and Experimental Medicine. https://doi.org/10.11648/j.ajcem.20221002.11
61. Birch, E. S., Stark, B. C., & Neumann, D. (2024). Factors related to social inferencing performance in moderate-severe, chronic TBI. Brain Injury. https://doi.org/10.1080/02699052.2024.2361634
62. Bitnun, A., & Richardson, S. E. (2015). Childhood Encephalitis in Canada in 2015. Canadian Journal of Infectious Diseases and Medical Microbiology. https://doi.org/10.1155/2015/947602
63. Blanco, S., Mitra, S., Howard, C. J., & Sumich, A. (2022). Psychological trauma, mood and social isolation do not explain elevated dissociation in functional neurological disorder (FND). Personality and Individual Differences. https://doi.org/10.1016/j.paid.2022.111952
64. Blomhoff, S., Diseth, T. H., Jacobsen, M., & Vatn, M. (2002). [Irritable bowel syndrome--a multifactorial disease in children and adults].. PubMed.
65. Blumenfeld, R. S. (2020). Neuropsychiatric Disorders. The Wiley Encyclopedia of Personality and Individual Differences. https://doi.org/10.1002/9781118970843.ch288
66. Blumenfeld, R. S. (2020). Neuropsychiatric Disorders. The Wiley Encyclopedia of Personality and Individual Differences. https://doi.org/10.1002/9781119547181.ch288
67. Bob, P., Selesova, P., Raboch, J., & Kukla, L. (2013). ‘Pseudoneurological’ symptoms, dissociation and stress-related psychopathology in healthy young adults. BMC Psychiatry. https://doi.org/10.1186/1471-244x-13-149
68. Bodien, Y. G., Fecchio, M., Freeman, H. J., Sanders, W. R., Meydan, A., Lawrence, P. K., Kirsch, J. E., Fischer, D., Cohen, J., Rubin, E., He, J., Schaefer, P. W., Hochberg, L. R., Rapalino, O., Cash, S. S., Young, M. J., & Edlow, B. L. (2024). Clinical Implementation of fMRI and EEG to Detect Cognitive Motor Dissociation. Neurology Clinical Practice. https://doi.org/10.1212/cpj.0000000000200390
69. Bondric‐Popescu, E.-C., & Cozman, D. (2022). Comorbidities associated with depression. Psihiatru ro. https://doi.org/10.26416/psih.68.1.2022.6308
70. Brandish, E. K., & Baldwin, D. S. (2012). Anxiety disorders. Medicine. https://doi.org/10.1016/j.mpmed.2012.08.017
71. Bransfield, R. C., & Friedman, K. J. (2019). Differentiating Psychosomatic, Somatopsychic, Multisystem Illnesses and Medical Uncertainty. Healthcare. https://doi.org/10.3390/healthcare7040114
72. Bravalhieri, A. A. V., Dontechef, P. D. S., Santos, J. D., Decanine, D., Pegorare, A. B. G. D. S., & Velasques, D. Z. (2016). Avaliação eletromiográfica dos músculos do assoalho pélvico em mulheres portadoras de Esclerose Múltipla e Mielopatia Associada ao HTLV-1 (HAM/TSP). 12º Congresso Internacional da Rede Unida.
73. Bravo, M. D. L. (2011). Ansiedad y depresión en la vejez.
74. Breen, L. J., Penman, E. L., Prigerson, H. G., & Hewitt, L. Y. (2015). Can Grief be a Mental Disorder?. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/nmd.0000000000000331
75. Brentar, J. (2008). Psychological Disorders and Functional Limitations.. Learning Disabilities: a Multidisciplinary Journal.
76. Brigo, F., & Mecarelli, O. (2019). Systemic and Dismetabolic Disorders. Clinical Electroencephalography. https://doi.org/10.1007/978-3-030-04573-9_42
77. Broers, D. (2010). Patiënten met ongewone extractiewensen 2. Wilsonbekwaamheid en psychopathologische oorzaken. Nederlands Tijdschrift voor Tandheelkunde. https://doi.org/10.5177/ntvt.2010.11.10121
78. Brown, R. (2019). Biopharmacologic and Neurophysiologic Basis of Addiction. Pain. https://doi.org/10.1007/978-3-319-99124-5_240
79. Brown, S. L. (2006). Deterioration. Epilepsia. https://doi.org/10.1111/j.1528-1167.2006.00682.x
80. Bugajska, J., Jędryka-Góral, A., Gasik, R., & Żołnierczyk-Zreda, D. (2011). [Acquired musculoskeletal dysfunction syndromes in workers in the light of epidemiological studies].. PubMed.
81. Bunk, S. F., Preis, L., Zuidema, S. U., Lautenbacher, S., & Kunz, M. (2019). Executive Functions and Pain. Zeitschrift für Neuropsychologie. https://doi.org/10.1024/1016-264x/a000264
82. Buris, L., Kercs, L., Posta, J., Somogyi, G., & Darok, M. (2001). [Medical judgement on driving capability].. PubMed.
83. Burke, A., Yaari, R., Tariot, P. N., Dougherty, J., Fleisher, A., & Brand, H. (2012). The Shadow People. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.12alz01398
84. Burns, J. M., & Login, I. S. (2002). Confounding factors in diagnosing brain death: a case report. BMC Neurology. https://doi.org/10.1186/1471-2377-2-5
85. Bykov, Y. N., & Kalyagin, A. N. (2015). Differential diagnosis of neuropathic pain. Neurology neuropsychiatry Psychosomatics. https://doi.org/10.14412/2074-2711-2015-1-4-10
86. Ca, S., Constantin, C., & Sîrbu, O. (2011). Transient visual loss due to neurological cause. Oftalmologia (Bucharest, Romania).
87. Cakmak, S. (2024). The Role of Physical Activity and Exercise in the Prevention and Treatment of Depression. International Journal of Computational and Experimental Science and Engineering. https://doi.org/10.22399/ijcesen.757
88. Cambra, P. R. (2021). Trastorno mental grave, pacientes con esquizofrenia.. Revista Sanitaria de Investigación.
89. Campoy, A. T., Rotger, M. Y., Gutiérrez, L. R. D. L. H., & Pastorelli, R. V. (2011). ¿Psicosis mental injertada o retraso mental? A propósito de un caso.. Psiquiatria.com.
90. Cappa, S. F., & Cipolotti, L. (2008). Cognitive and behavioural disorders associated with space-occupying lesions. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780198569275.003.0010
91. Carney, R. M., & Freedland, K. E. (2000). Depression and Medical Illness. https://doi.org/10.1093/oso/9780195083316.003.0009
92. Carolina, P. J., & William, B. (2013). Neuropsicología en epilepsia. Revista Médica Clínica Las Condes. https://doi.org/10.1016/s0716-8640(13)70253-0
93. Carota, A., Diéguez, S., & Bogousslavsky, J. (2005). Psychopathology of stroke. Gériatrie et Psychologie Neuropsychiatrie du Viellissement.
94. Caruso, G. M., & Kertay, L. (2019). Part I: Psychological Factors in Delayed and Failed Recovery and Unnecessary Disability. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2019.mayjun01
95. Cavanna, A. E., & Rickards, H. (2020). Neuropsychiatric aspects of movement disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198757139.003.0018
96. Cernovsky, Z. Z., Ferrari, J. R., & Mendonça, J. D. (2019). Deceptive Clinical Diagnosing of Malingering via Structured Inventory of Malingered Symptomatology. Archives of Psychiatry and Behavioral Sciences. https://doi.org/10.22259/2638-5201.0201009
97. Chaban, V. V. (2016). Irritable Bowel Syndrome: Functional Gastrointestinal Disease Regulated by Nervous System. InTech eBooks. https://doi.org/10.5772/65767
98. Chadha, Y., Toshniwal, S., & Patil, R. (2024). Diagnostic Dilemma: Unraveling Meige Disorder Mistaken for Functional Neurological Disorder. Cureus. https://doi.org/10.7759/cureus.61465
99. Chandrasekaran, S., Shiva, J., Makaram, N., Karthick, P. A., & Swaminathan, R. (2020). Analysis of Surface Electromyography Signals in Fatigue Conditions Under Dynamic Contractions Using Time Difference of Muscle Activations. https://doi.org/10.1109/spmb50085.2020.9353638
100. Charil, A., & Inglese, M. (2012). Predicting short-term conversion from CIS to MS. Neurology. https://doi.org/10.1212/wnl.0b013e31827dec22
101. Charles, A. (2012). Migraine is not primarily a vascular disorder. Cephalalgia. https://doi.org/10.1177/0333102412441717
102. Chaudhary, B., & Chaudhary, A. (2020). Multiple sclerosis: making the invisibles visible. International Journal of Research in Medical Sciences. https://doi.org/10.18203/2320-6012.ijrms20202093
103. Chaudhry, H., Arshad, N., Niaz, S., Cheema, F., Iqbal, M., & Mufti, K. (2005). Fifteen-year follow-up of conversion disorder. International Psychiatry. https://doi.org/10.1192/s1749367600007517
104. Chen, J., Xue, K., Yang, M., Wang, K., Xu, Y., Wen, B., Cheng, J., Han, S., & Wei, Y. (2022). Altered Coupling of Cerebral Blood Flow and Functional Connectivity Strength in First-Episode Schizophrenia Patients With Auditory Verbal Hallucinations. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2022.821078
105. Cheshire, W. P. (2016). Autonomic Physiology. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190259631.003.0035
106. Chin, A. C. (2020). PERK-STING Signaling Drives Neuroinflammation in Traumatic Brain Injury. Journal of Neuroscience. https://doi.org/10.1523/jneurosci.2881-19.2020
107. Chou, R., Norris, S. L., Carson, S., & Chan, B. (2007). Drug Class Review: Drugs for Neuropathic Pain: Final Report [Internet].
108. Ciołkiewicz, M., Kuryliszyn-Moskal, A., Hryniewicz, A., & Kamiński, K. (2019). Sarcopenia and myokines profile as risk factors in cardiovascular diseases?. Postępy Higieny i Medycyny Doświadczalnej. https://doi.org/10.5604/01.3001.0013.5442
109. Clarke, C. (2022). Neuropsychiatry. Neurology. https://doi.org/10.1002/9781119235699.ch22
110. Clauw, D. J. (2010). Perspectives on Fatigue from the Study of Chronic Fatigue Syndrome and Related Conditions. PM&R. https://doi.org/10.1016/j.pmrj.2010.04.010
111. Cleeland, C. S., & Mendoza, T. R. (2010). Symptom measurement by patient report. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511780868.028
112. Cloak, N. L., & Khalili, Y. A. (2020). Behavioral And Psychological Symptoms In Dementia. StatPearls.
113. Clère, F. (2008). Antiépileptiques et douleurs neuropathiques. Médecine. https://doi.org/10.1684/med.2008.0323
114. Coffey, R. J., & Caroff, S. N. (2024). Neurosurgery for mental conditions and pain: An historical perspective on the limits of biological determinism. Surgical Neurology International. https://doi.org/10.25259/sni_819_2024
115. Connors, M. H., Kinder, J., Swift, E., Kanaan, R., Sachdev, P. S., & Mohan, A. (2024). Functional neurological disorder clinics in Australasia: A binational survey. Journal of Clinical Neuroscience. https://doi.org/10.1016/j.jocn.2024.05.043
116. Conway, K. P., Montoya, I. D., & Compton, W. M. (2007). Lifetime Psychiatric Comorbidity of Illicit Drug Use Disorders. The Psychiatric times.
117. Copeland‐Linder, N., Onigu-Otite, E., Serico, J. M., Jamora, M., & Belcher, H. M. E. (2017). Neurobiology of Child Maltreatment and Psychological Trauma. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199937837.003.0181
118. Cordero, R., & Lisseth, M. (2015). Estudio de caso, diagnostico e intervención psicológica para mejorar el deterioro funcional de un paciente con esquizofrenia..
119. Costello, K., & Newsome, S. D. (2017). Symptoms of Multiple Sclerosis. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199937837.003.0085
120. Couto, F. S. D., & Mendonça, A. D. (2010). Sintomas psiquiátricos e comportamentais da demência. Revista Portuguesa de Clínica Geral. https://doi.org/10.32385/rpmgf.v26i1.10713
121. Crecan-Suciu, B. D., & Paunescu, R. (2022). New Directions for Symptoms and Diagnosis in Schizophrenia. IntechOpen eBooks. https://doi.org/10.5772/intechopen.106806
122. Crespo‐Facorro, B., Manes, F., Plebst, C., & Morcuende, M. A. (1999). [Biological markers of schizophrenic symptoms: functional neuroimaging].. PubMed.
123. Cummings, J. L., & Zhong, K. (2017). Promise and Challenges in Drug Development and Assessment for Cognitive Enhancers. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214401.003.0001
124. Cáceres, F., Baca, G. H. R., Osorto, L. J. R., Godoy, K. J. Á., Hernández, G. R. O., Barahona, R. D. S., Sorto, N. D. Z., Suárez, M., Anduray, A. S. M., Mendoza, K. V. J., & Vargas, G. H. R. (2024). Síndrome Convulsivo. Religación Press eBooks. https://doi.org/10.46652/religacionpress.195.c296
125. Dadkhah, B., Valizadeh, S., Mohammadi, E., & Hassankhani, H. (2013). Psychosocial adjustment to lower-limb amputation: A review article.
126. Dafotakis, M. (2012). Psychogene Bewegungsstörungen - Klinische Präsentation. Klinische Neurophysiologie. https://doi.org/10.1055/s-0032-1301499
127. Daley, D. C., & Douaihy, A. (2019). Substance-Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0002
128. Dalvi, A., Lyons, K. E., & Pahwa, R. (2012). Secondary dystonia. CRC Press eBooks. https://doi.org/10.3109/9781841848525-20
129. David, A. S. (2010). 031 Self awareness and insight in neuropsychiatric disorders. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2010.217554.31
130. Davidson, W. S., & Onifade, E. (2010). Deviancy. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0269
131. Delgado, S., Wassenaar, E., & Strawn, J. R. (2011). Does Your Patient Have a Psychiatric Illness or Nonverbal Learning Disorder? Clinical Clues Help Differentiate Overlapping Symptoms and Syndromes. Current psychiatry.
132. Delgado‐Losada, M. L., Aizcorbe, J. R. R., & Guinea, S. F. (2001). Aspectos de la Neuropsicología Forense en el envejecimiento y en las demencias. Revista de Neurología. https://doi.org/10.33588/rn.3208.2000187
133. Dennis, L. A., & Phipps, W. D. (2020). Functional Neurological Symptom Disorder (Conversion Disorder) from an Interactional Approach: A Composite Case Study. Australian and New Zealand Journal of Family Therapy. https://doi.org/10.1002/anzf.1434
134. Derouesné, C. (1995). [Conversion hysteria].. PubMed.
135. Desseilles, M., Sterpenich, V., Dang‐Vu, T. T., & Schwartz, S. (2011). REM sleep and emotion regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511921179.044
136. Dias, R. D. S. (2010). Estudo comparativo do fenótipo clínico de mulheres com transtorno afetivo bipolar em fase reprodutiva da vida com e sem piora pré-menstrual do humor. https://doi.org/10.11606/t.5.2010.tde-28052010-101220
137. Dickerson, B. C., & Sperling, R. A. (2007). Dementia: mild cognitive impairment and Alzheimer’s disease. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198566298.003.0005
138. DM, F. P. G. M., BSc, M. P. C. B., Boyd, D. M., & BSc, M. D. S. S. (2014). Major Medical Problems. https://doi.org/10.1002/9781118690345.ch8
139. Dobrakowski, P., Pierzchała, K., & Łabuz-Roszak, B. (2013). [Sexual dysfunctions and sexual satisfaction among multiple sclerosis patients].. PubMed.
140. Dodel, R. (2010). Kognitive Störungen bei neurologischen Erkrankungen. Nervenheilkunde. https://doi.org/10.1055/s-0038-1628846
141. Dodick, D. W., & Roarke, M. C. (2007). Familial Hemiplegic Migraine: Permanent Attack‐Related Neurologic Deficits. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/j.1526-4610.2007.00889.x
142. Doll, B. (2007). Aktuelles Management bei Kindern mit zerebralen Bewegungsstörungen. Orthopädie und Unfallchirurgie up2date. https://doi.org/10.1055/s-2007-995375
143. Dols, A., Rhebergen, D., Eikelenboom, P., & Stek, M. L. (2010). Melancholie; verstoorde beweging of ontstemd gemoed?. Tijdschrift voor psychiatrie.
144. Donkelaar, P. V., Osternig, L. R., & Chou, L. (2006). Attentional and Biomechanical Deficits Interact After Mild Traumatic Brain Injury. Exercise and Sport Sciences Reviews. https://doi.org/10.1249/00003677-200604000-00007
145. DrSc, K. Š. (2008). Poruchy pohybu a chování ve spánku. Neurologie pro praxi.
146. Dua, T. (2021). Commentary on Mental Illness, it?s Causes and Prevention. Brain Disorders & Therapy.
147. Dubovsky, S., & Thomas, M. R. (1995). Serotonergic mechanisms and current and future psychiatric practice.. PubMed.
148. Dujmović, D., Brkljačić, M., Kučer, N., Matijatko, V., Jurkić, G., & Kiš, I. (2022). Hitna stanja u neurologiji. Veterinarska stanica. https://doi.org/10.46419/vs.53.5.3
149. D’cruz, M., Andrade, C., & Rao, T. S. (2020). The Expression of Intimacy and Sexuality in Persons With Dementia. Journal of Psychosexual Health. https://doi.org/10.1177/2631831820972859
150. D’Souza, R. S., & Hooten, W. M. (2019). Somatic Syndrome Disorders.
151. Ebenezer, I. S. (2015). Sleep and Sleep Disorders. https://doi.org/10.1002/9781118385777.ch9
152. Egloff, N., Maecker, F., Stauber, S., Sabbioni, M., Tunklova, L., & Känel, R. V. (2013). Hysterie? Nicht dermatombezogene somatosensorische Defizite. Journal Club Schmerzmedizin. https://doi.org/10.1055/s-0033-1334068
153. Egloff, N., Schwegler, K., & Holtforth, M. G. (2019). Funktionelle Körperbeschwerden. Therapeutische Umschau. https://doi.org/10.1024/0040-5930/a001093
154. Elbasiouny, S. M. (2022). Motoneuron excitability dysfunction in ALS: Pseudo‐mystery or authentic conundrum?. The Journal of Physiology. https://doi.org/10.1113/jp283630
155. Elst, L. T. V., Stich, O., & Endres, D. (2015). Depressionen und Psychosen bei immunologischen Enzephalopathien. PSYCH up2date. https://doi.org/10.1055/s-0041-102941
156. Enck, R. E. (2013). Palliative Medicine. Home Health Care Management & Practice. https://doi.org/10.1177/1084822313486149
157. Engel, C., Greim, B., & Zettl, U. K. (2007). [Diagnostic of cognitive dysfunctions in multiple sclerosis].. Versicherungsmedizin.
158. Engel, J., Caldecott-Hazard, S., & Bandler, R. (1986). Neurobiology of Behavior: Anatomic and Physiological Implications Related to Epilepsy. Epilepsia. https://doi.org/10.1111/j.1528-1157.1986.tb05739.x
159. Errante, P. R. (2022). Canine Cognitive Dysfunction Syndrome a Challenge in Treatment and Improvement in Quality Life of Older Dogs. International Journal of Zoology and Animal Biology. https://doi.org/10.23880/izab-16000424
160. Escobar, A. J. S. (2002). Avances en síndrome de intestino irritable. Revista Facultad Ciencias de la Salud: Universidad del Cauca.
161. Espay, A. J., Aybek, S., Carson, A., Edwards, M. J., Goldstein, L. H., Hallett, M., LaFaver, K., LaFrance, W. C., Lang, A. E., Nicholson, T. R., Nielsen, G., Reuber, M., Voon, V., Stone, J., & Morgante, F. (2018). Current Concepts in Diagnosis and Treatment of Functional Neurological Disorders. JAMA Neurology. https://doi.org/10.1001/jamaneurol.2018.1264
162. Esteves-Sousa, D., Albuquerque, M., Facucho-Oliveira, J., Santos, P. E. D., Costa, M. S., Chai, M. V., Mendonça, L., & Tropa, J. (2019). ANTIPSYCHOTIC AGENTS, UNDERNEATH THEIR ACTION – STRENGTHS AND SHORTCOMINGS. https://doi.org/10.26226/morressier.5d1a037657558b317a14069b
163. Falk, M. J., & Moreno, M. A. (2019). What Parents Need to Know About Genetic Testing. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2019.0005
164. Farrer, F. (2008). Understanding Restless Legs Syndrome. Obstetrics and Gynaecology Forum.
165. Feinstein, A. (2008). Psychogenic aphonia: spectacular recovery after motor cortex transcranial magnetic stimulation. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2008.162842
166. Feltz, C. V. D., & Houdenhove, B. V. (2014). [DSM-5: from 'somatoform disorders' to 'somatic symptom and related disorders'].. PubMed.
167. Fernández‐Jaén, A., Martín, S. L., Albert, J., Mayoralas, D. M. F., Perrone, A. L. F., Pérez, B., & Arribas, S. L. (2017). Trastorno por déficit de atención/hiperactividad. Revista de Neurología.
168. Ferrier, I. N. (1993). Comparisons of Clinical Efficacy. The British Journal of Psychiatry. https://doi.org/10.1192/s0007125000292337
169. ffytche, D., Blom, J. D., & Catani, M. (2010). Disorders of visual perception. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2008.171348
170. Fineschi, S., Fahlström, M., Fällmar, D., Haller, S., & Wikström, J. (2024). Comprehensive MRI assessment reveals subtle brain findings in non-hospitalized post-COVID patients with cognitive impairment. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2024.1435218
171. Finlayson, A. (2020). Psychotherapy and Psychological Aspects of Recovery from Brain Injury. Taylor & Francis eBooks. https://doi.org/10.1201/9780367810535-22
172. Fisher, A. D., Bandini, E., Casale, H., & Maggi, M. (2011). Paraphilic Disorders: Diagnosis and Treatment. https://doi.org/10.1002/9781119963820.ch8
173. Flanigan, M. E., & LeClair, K. B. (2017). Shared Motivational Functions of Ventral Striatum D1 and D2 Medium Spiny Neurons. Journal of Neuroscience. https://doi.org/10.1523/jneurosci.0882-17.2017
174. Fogel, B. S. (2015). Physical and Neurological Examination. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199731855.003.0002
175. Foster, J. K. (2008). 5. Memory impairment. Oxford University Press eBooks. https://doi.org/10.1093/actrade/9780192806758.003.0005
176. Fragoso, Y. D., Rocha, F. B., Beloni, T. M. N., Orquiza, B., Rosa, P. B., Donadel, R. W., Aniceto, J. T., & Diniz, R. P. (2016). Driving Ability among Patients with Multiple Sclerosis: Can Legislation Be Provided on the Matter?. Critical Reviews in Physical and Rehabilitation Medicine. https://doi.org/10.1615/critrevphysrehabilmed.2017020023
177. Francàs, N. S. (2012). Percepción de fatiga central en la enfermedad de parkinson: factores clínicos, psicopatológicos y neuropsicológicos. TDX (Tesis Doctorals en Xarxa).
178. Galderisi, S. (2012). W04-03 - Psychosocial functioning - relationship with symptoms and cognitive impairment. European Psychiatry. https://doi.org/10.1016/s0924-9338(12)75680-8
179. Gallego, D., Figueroa, J., & Orozco, C. (2010). Síndrome de disfunción cognitiva de perros geriátrico. Revista Mvz Córdoba. https://doi.org/10.21897/rmvz.313
180. Gandolfi, M., Sandri, A., Mariotto, S., Tamburin, S., Paolicelli, A. M., Fiorio, M., Pedrotti, G., Barone, P., Pellecchia, M. T., Erro, R., Cuoco, S., Carotenuto, I., Vinciguerra, C., Botto, A., Zenere, L., Canu, E., Sibilla, E., Filippi, M., Sarasso, E., ... Tinazzi, M. (2024). A window into the mind-brain-body interplay: Development of diagnostic, prognostic biomarkers, and rehabilitation strategies in functional motor disorders. PLoS ONE. https://doi.org/10.1371/journal.pone.0309408
181. García, M. D. S., & Calderón, R. M. (2010). Síntomas no motores en la enfermedad de Parkinson y estimulación cerebral profunda. Revista de Neurología. https://doi.org/10.33588/rn.50s02.2009745
182. Garrido, G., Camps, L., Herrera, I. H., Guillamat, R., Vallés, V., Sanz, M., & Martínez, J. (2016). Music &amp; Wellbeing. International Journal of Integrated Care. https://doi.org/10.5334/ijic.2734
183. Garriga-Grimau, L., Laín, G. A., Nascimiento, M. T., & Aleman, A. P. (2015). Síndrome cerebeloso cognitivo-afectivo. Archivos Argentinos de Pediatria. https://doi.org/10.5546/aap.2015.e268
184. Gelatt, K. N., & Plummer, C. E. (2017). Neuro‐ophthalmic Syndromes. https://doi.org/10.1002/9781119239680.ch19
185. George, O., & Koob, G. F. (2017). Individual differences in the neuropsychopathology of addiction. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2017.19.3/gkoob
186. Geraldes, R., Coelho, M., Rosa, M. M., Severino, L., Castro, J., & Carvalho, M. D. (2008). Abnormal transcranial magnetic stimulation in a patient with presumed psychogenic paralysis. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2008.154583
187. Gertz, H.-J. (2001). Dementias in Other Brain Diseases. Contemporary psychiatry. https://doi.org/10.1007/978-3-642-59519-6_74
188. Ghaemi, S. N. (2018). Treatment of Personality. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199995486.003.0021
189. Ghosh, S. (2015). Better understanding of etiopathology needed to develop novel treatments. Medicus.
190. Giazkoulidou, A., Messinis, L., & Nasios, G. (2019). Cognitive functions and social cognition in multiple sclerosis: An overview.. PubMed.
191. Gilbert‐Barness, E., Debich-Spicer, D., & Opitz, J. M. (2001). Malformation Syndromes. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511547423.010
192. Gioacchino, M. D., Boscolo, P., Reale, M., Muraro, R., & Giampaolo, L. D. (2011). Work stress and innate immune response.. International Journal of Immunopathology and Pharmacology.
193. Glassford, J. A. G. (2017). The Neuroinflammatory Etiopathology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Frontiers in Physiology. https://doi.org/10.3389/fphys.2017.00088
194. Goel, P., Khurshid, A., Sharma, M., Irshad, N., Chachra, S., & Dhindsa, A. (2020). Psychological development: milestones from birth to adolescent. International Journal of Indian Psychology. https://doi.org/10.25215/0802.056
195. Gold, B. G., Schnell, J. V., & Spencer, P. S. (2003). Neurotoxic Disorders. https://doi.org/10.1007/978-1-4757-4552-8_14
196. Goldberg, T. E., Berman, K. F., & Weinberger, D. R. (1995). Neuropsychology and neurophysiology of schizophrenia. Current Opinion in Psychiatry. https://doi.org/10.1097/00001504-199501000-00009
197. Goldstein, D. S. (2002). Dysautonomias: Clinical Disorders of the Autonomic Nervous System. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-137-9-200211050-00011
198. González, M. J., Bardanca, M. S. G., Vivanco, E. F., Paz, M. T. A., & Allegue, M. D. (2007). Distonía psicógena: un diagnóstico complejo..
199. Goodin, D. S. (2006). Physical Trauma, Psychological Stress, and Multiple Sclerosis. https://doi.org/10.1093/oso/9780195170320.003.0037
200. Goodman, B. P., & Benarroch, E. E. (2013). Autonomic Manifestations of Systemic Disease. https://doi.org/10.1002/9781118414019.ch14
201. Goodwin, G. M. (2006). Depression and associated physical diseases and symptoms. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2006.8.2/mgoodwin
202. Gordon, E., & Mayer, S. A. (2020). Coma and Brain Death. https://doi.org/10.1002/9781119293255.ch31
203. Gracely, R. H. (2003). Is seeing believing? Functional imaging of hysterical anesthesia. Neurology. https://doi.org/10.1212/wnl.60.9.1410
204. Graham, D. (1967). Health, Disease, and the Mind-Body Problem: Linguistic Parallelism. Psychosomatic Medicine. https://doi.org/10.1097/00006842-196701000-00006
205. Grashow, R., Eagle, S. R., Terry, D. P., DiGregorio, H., Baggish, A. L., Weisskopf, M. G., Kontos, A. P., Okonkwo, D. O., & Zafonte, R. (2024). Medical Conditions in Former Professional American-Style Football Players Are Associated With Self-Reported Clinical Features of Traumatic Encephalopathy Syndrome. Neurotrauma Reports. https://doi.org/10.1089/neur.2024.0008
206. Green, M. F., & Horan, W. P. (2010). Social Cognition in Schizophrenia. Current Directions in Psychological Science. https://doi.org/10.1177/0963721410377600
207. Green, M. F., Kern, R. S., Robertson, M. J., Sergi, M. J., & Kee, K. S. (2000). Relevance of neurocognitive deficits for functional outcome in schizophrenia. https://doi.org/10.1093/oso/9780192629937.003.0009
208. Greenberg, B. (2007). Neurology. https://doi.org/10.1093/oso/9780195188493.003.0010
209. Grigorean, V. T., & Coman, I. S. (2021). Diagnostic and Therapeutic Particularities in Abdominal Trauma Associated with Spinal Cord Injuries - Review of the Literature. Chirurgia. https://doi.org/10.21614/chirurgia.116.6.669
210. Groh, A. M. (2019). Exercise as Therapy for Depression: A Review of the Positive Psychosocial and Psychobiological Effects of Physical Activity. Western Undergraduate Psychology Journal.
211. Gruezo-Realpe, P., Cusme-Diaz, N., León-Llanos, H. A., Benavides-López, A., & Yanzaguano-Morquecho, V. (2022). Fibromialgia: Manifestaciones neuropsiquiátricas y abordaje terapéutico en la atención primaria. Revista Reumatología al Día.. https://doi.org/10.62484/rad.v16i3.5261
212. Guerdjikova, A. I., McElroy, S. L., Barger, S. D., Barth, J., Farrelly, S., & Brohan, E. (2019). Recent Advances in Depressive Disorder.
213. Gurgel, L. G., Dourado, M. R., Moreira, T. D. C., Serafini, A. J., Menegotto, I. H., Reppold, C. T., & Soldera, C. L. C. (2012). Correlation between vestibular test results and self-reported psychological complaints of patients with vestibular symptoms. Brazilian Journal of Otorhinolaryngology. https://doi.org/10.1590/s1808-86942012000100010
214. Guskiewicz, K. M., & Goldman, S. B. (2013). A Changing Landscape: Traumatic Brain Injury in Military Combat and Civilian Athletics. The FASEB Journal. https://doi.org/10.1096/fj.13-1101ufm
215. Guthrie, E., & Nayak, A. (2012). Medically unexplained symptoms.
216. Haddad, P., & Benbow, S. (1992). Visual Hallucinations as the Presenting Symptom of Senile Dementia. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.161.2.263
217. Hadi, I., Wijayati, F., Usman, R. D., & Rosyanti, L. (2017). Major Depressive Disorder: A Mini Review. Health Information Jurnal Penelitian. https://doi.org/10.36990/hijp.v9i1.102
218. Hafeza, M. J., Bourjia, H., & Sroura, H. (2020). Functional Neurological Deficit: one of the most controversial diagnosis- case report of a patient with paraplegia. International Journal of Case Reports. https://doi.org/10.28933/ijcr-2020-02-2305
219. Haidbauer, A. (2004). Post-operative analgesia. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544477.032
220. Hainline, B., Gurin, L., & Torres, D. M. (2019). Cognitive Dysfunction Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0034
221. Hainline, B., Gurin, L., & Torres, D. M. (2019). Unmasking Neuropsychiatric Disorders Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0035
222. Halicka, M., Vittersø, A. D., Proulx, M. J., & Bultitude, J. H. (2020). Neuropsychological Changes in Complex Regional Pain Syndrome (CRPS). Behavioural Neurology. https://doi.org/10.1155/2020/4561831
223. Hao, Y., Controzzi, M., Cipriani, C., Popović, D. B., Yang, X., Chen, W., Zheng, X., & Carrozza, M. C. (2013). Controlling hand-assistive devices: utilizing electrooculography as a substitute for vision. IEEE Robotics & Automation Magazine. https://doi.org/10.1109/mra.2012.2229949
224. Harrington, E., Gamaldo, A., Felt, J. M., Witzel, D., Sliwinski, M. J., Murdock, K. W., Engeland, C. G., & Graham‐Engeland, J. E. (2024). Racial differences in links between perceived discrimination, depressive symptoms, and ambulatory working memory. Aging & Mental Health. https://doi.org/10.1080/13607863.2024.2351923
225. Hartman, T. O., Dowrick, C., Lam, C. L. K., Fortes, S., Clarke, D. D., & Usta, J. (2019). Medically unexplained symptoms. Routledge eBooks. https://doi.org/10.4324/9780429026386-4
226. Hartung, P. J., & Penn, M. A. (2004). Work Stress and Health. https://doi.org/10.1093/oso/9780195149395.003.0041
227. Harvey, P. D. (2011). Assessment of everyday functioning in schizophrenia.. PubMed.
228. Hausteiner‐Wiehle, C. (2022). Funktionelle Körperbeschwerden: Klinische Vielfalt, diagnostische Herausforderungen, therapeutische Prinzipien. DMW - Deutsche Medizinische Wochenschrift. https://doi.org/10.1055/a-1554-1662
229. Hawley, C. J., Schoene, B., Harmon, K. G., & Rubin, A. D. (2003). Overtraining Syndrome. The Physician and Sportsmedicine. https://doi.org/10.1080/00913847.2003.11440605
230. Henderson, A. S. (1990). Co-Occurrence of Affective and Cognitive Symptoms: The Epidemiological Evidence. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000107130
231. Hennessy, M. B., Deak, T., & Schiml‐Webb, P. A. (2001). Stress‐induced sickness behaviors: An alternative hypothesis for responses during maternal separation. Developmental Psychobiology. https://doi.org/10.1002/dev.1031
232. Hermans, M. C. E., Faber, C. G., Vanhoutte, E. K., Bakkers, M., Baets, M. H. D., Die‐Smulders, C. D., & Merkies, I. S. J. (2011). Peripheral neuropathy in myotonic dystrophy type 1. Journal of the Peripheral Nervous System. https://doi.org/10.1111/j.1529-8027.2011.00313.x
233. Hill, P. (2006). Adjustment disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543807.008
234. Hiro, H., & Nagata, M. (2015). Support of workers with Developmental Disorders. Stress Science Research. https://doi.org/10.5058/stresskagakukenkyu.30.35
235. Horowitz, S. H. (2002). Criteria for the diagnosis of peripheral neuropathies. Occupational and Environmental Medicine. https://doi.org/10.1136/oem.59.7.425
236. Hrynevych, K., & Kopchak, О. (2025). Hidden manifestations of multiple sclerosis: a current view on pathogenesis and clinical significance. INTERNATIONAL NEUROLOGICAL JOURNAL. https://doi.org/10.22141/2224-0713.21.5.2025.1195
237. Huda, A. S. (2019). Biological factors and health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0012
238. Huda, A. S. (2019). Social factors and health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0013
239. Huda, A. S. (2019). Spectrums of conditions. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0011
240. Huda, A. S. (2019). Spectrums of health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0009
241. Huda, A. S. (2019). Variability of clinical picture. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0010
242. Hunt, T. J., Thienhaus, O. J., & Ellwood, A. (2008). The mirror lies: body dysmorphic disorder.. PubMed.
243. Huron, C. (2017). Developmental Coordination Disorder. The SAGE Encyclopedia of Abnormal and Clinical Psychology. https://doi.org/10.4135/9781483365817.n425
244. Hwangbo, J., Kang, M., & Ji, K. (2020). A New Positive Sign of Functional Weakness in Conversion Disorder: Polysomnography with Extended Surface Electromyography. Journal of Sleep Medicine. https://doi.org/10.13078/jsm.200025
245. Hybels, C. F., Blazer, D. G., & Steffens, D. C. (2006). Partial remission. A common outcome in older adults treated for major depression.. PubMed.
246. Häfele, M. (2001). Internistische Differenzialdiagnose bei unklaren Bewusstseinsstörungen in Verbindung mit synkopalen Zuständen oder epileptischen Anfällen. Aktuelle Neurologie. https://doi.org/10.1055/s-2001-15333
247. Häuser, W., Dinkel, A., & Lahmann, C. (2012). Funktionelle gastrointestinale Störungen. Psychiatrie und Psychotherapie up2date. https://doi.org/10.1055/s-0032-1304958
248. Ianisky, R., Wrubleski, T., Tafarel, J. R., Magalhães, M. F., & Dias, V. (2020). Raro caso de trombose venosa cerebral apresentando-se com cefaleia e alucinações visuais. Deleted Journal. https://doi.org/10.48208/headachemed.2020.supplement.33
249. Impey, B., Gordon, R. P., & Baldwin, D. S. (2020). Anxiety disorders, post-traumatic stress disorder, and obsessive–compulsive disorder. Medicine. https://doi.org/10.1016/j.mpmed.2020.08.005
250. Isenberg, K., & Garcia, K. S. (2008). Syndromes of Brain Dysfunction Presenting with Cognitive Impairment or Behavioral Disturbance: Delirium, Dementia, and Mental Disorders Caused by a General Medical Condition. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-252-6_2
251. Ishiai, S. (2024). [Unilteral Spatial Neglect: Clinical Manifestations and Neural Correlates].. PubMed. https://doi.org/10.11477/mf.1416202673
252. Ivanova, E. O., & Fedotova, E. Y. (2018). Функциональные двигательные расстройства: позитивные критерии диагностики. Неврология, нейропсихиатрия, психосоматика.
253. Jain, S., Goel, S., & Kapila, S. (2015). Clinical Evaluation Of Psychiatric Emergencies.
254. Jain, S., Kothari, S., Rohith, V. S., Kumar, H., & Jain, C. (2024). The Relationship Between Auditory and Cognitive Processing Abilities in Children With Specific Learning Disorders. American Journal of Audiology. https://doi.org/10.1044/2024_aja-24-00001
255. Jakl, M., Skořepa, P., & Horáček, J. M. (2016). IMPACT OF EXTREME PHYSICAL EXERCISE ON HUMAN BODY. Military Medical Science Letters. https://doi.org/10.31482/mmsl.2016.026
256. Jang, H.-H., In-Seon, K., Hyung-cheol, M., Yoo-Jin, H., Lyu, Y.-S., & Hyung-Won, K. (2001). A Study on The Oriental-medical Understanding of Depression. Journal of Oriental Neuropsychiatry.
257. Jankovic, J. (2008). Parkinson's disease: clinical features and diagnosis. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2007.131045
258. Jensen, T. S. (2002). An improved understanding of neuropathic pain. European Journal of Pain. https://doi.org/10.1016/s1090-3801(02)90002-9
259. Jensen, T. S. (2007). 19 NEUROPATHIC PAIN: DEFINITION AND SCREENING. European Journal of Pain. https://doi.org/10.1016/j.ejpain.2007.03.033
260. Johnson, M. H. (2001). Assessing confused patients.. PubMed. https://doi.org/10.1136/jnnp.71.suppl_1.i7
261. Jones, R. (1962). Pharmacotherapy of Psychosis with Mixed Symptomatology. Canadian Psychiatric Association Journal. https://doi.org/10.1177/070674376200701s12
262. Jurenec, G. S. (2017). The Phenomenological Experience of Schizophrenia and Affective Function. Acta Psychopathologica. https://doi.org/10.4172/2469-6676.100139
263. Jääskeläinen, S. K. (2006). Neuropathic pain in the orofacial area. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198569817.003.0007
264. Kadiyala, S., Bhamidipati, P., & Malla, R. R. (2024). Neuroplasticity: Pathophysiology and Role in Major Depressive Disorder. Critical Reviews™ in Oncogenesis. https://doi.org/10.1615/critrevoncog.2024051197
265. Kaiser, S., Heekeren, K., & Simon, J. J. (2011). The Negative Symptoms of Schizophrenia: Category or Continuum?. Psychopathology. https://doi.org/10.1159/000325912
266. Kaiser, S., Mundt, C., & Weisbrod, M. (2005). Exekutive Kontrollfunktionen und Neuropsychiatrische Erkrankungen - Perspektiven für Forschung und Klinik. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2004-830303
267. Kalayjian, L. A., & Morrell, M. J. (2000). Female Sexuality and Neurological Disease. Journal of Sex Education and Therapy. https://doi.org/10.1080/01614576.2000.11074333
268. Kalyani, N., Sullivan, K. A., Moyle, G., Brauer, S., Jeffrey, E. R., & Kerr, G. (2019). Effects of dance on cognitive functions, psychological symptoms and health-related quality of life in Parkinson’s disease.
269. Kandagal, S., Shenai, P., & Chatra, L. (2012). EFFECT OF STRESS ON ORAL MUCOSA – REVIEW. Biomedical Reports.
270. Kapur, N., & Kemp, S. (2024). Words Matter. Neurology Clinical Practice. https://doi.org/10.1212/cpj.0000000000200238
271. Karri, J., Chien, G. C. C., & Abd‐Elsayed, A. (2019). Nerve Entrapments of the Lower Extremity. Pain. https://doi.org/10.1007/978-3-319-99124-5_166
272. Kasatkin, D. S. (2006). [Possible mechanisms of chronic fatigue syndrome in multiple sclerosis].. PubMed.
273. Katz, P. (2006). Function, Disability, and Psychological Well-Being. KARGER eBooks. https://doi.org/10.1159/000095365
274. Kennedy, S. H. (2008). Core symptoms of major depressive disorder: relevance to diagnosis and treatment. Dialogues in Clinical Neuroscience. https://doi.org/10.31887/dcns.2008.10.3/shkennedy
275. Khandelwal, S., & Desai, M. (2024). Prevalence of Fatigue Among Female Academicians. International Journal of Health Sciences and Research. https://doi.org/10.52403/ijhsr.20240324
276. Kholin, V., In, K., Kryzhanovskiy, S., Karasevich, N., Khodakovska, M., Shershanova, H., & Movchun, N. O. (2024). Cognitive disorders in Parkinson's disease. Ageing & Longevity. https://doi.org/10.47855/jal9020-2024-5-6
277. Kim, J. S., Hong, S. B., Park, K.-W., & Lee, A. (2024). Psychotic Symptoms in Patients With Major Neurological Diseases. Journal of Clinical Neurology. https://doi.org/10.3988/jcn.2023.0501
278. Kim, K. M., Bae, E. J., Lee, J., Park, T. W., & Lim, M. H. (2021). A Review of Cognitive and Behavioral Interventions for Tic Disorder. Journal of korean Academy of Child and Adolescent Psychiatry. https://doi.org/10.5765/jkacap.200042
279. Kim, S.-H., & Jung, S.-W. (2011). Psychiatric Approach of Fibromyalgia. Journal of Rheumatic Diseases. https://doi.org/10.4078/jrd.2011.18.4.242
280. King, B. H. (2001). Psychopharmacology in intellectual disabilities. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511543616.020
281. Knaap, M. S. V. D., Depienne, C., Sedel, F., & Abbink, T. E. M. (2015). CLCN2-Related Leukoencephalopathy.
282. Knardahl, S. (2005). Psychological and social factors at work: contribution to musculoskeletal disorders and disabilities.. Giornale italiano di medicina del lavoro ed ergonomia.
283. Kondo, T., & Ishiguchi, H. (2007). 3. Drug Induced Dyskinesia. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.96.1621
284. Konez, O., Pascual-Castroviejo, I., Rocco, C. D., & Ruggieri, M. (2008). Sturge-Weber Syndrome. https://doi.org/10.1007/978-3-211-69500-5_10
285. Konichezky, A., & Gothelf, D. (2011). [Somatoform disorders in children and adolescents].. PubMed.
286. Koops, E. A., Belkum, S. V., Hanekamp, S., Noort, P., Broersma, M., & Beilen, M. V. (2017). Non-invasive neuromodulation as a new therapeutic strategy in the management of functional somatic symptoms.
287. Kos, D., Kerckhofs, E., Nagels, G., D’hooghe, M., & Ilsbroukx, S. (2007). Origin of Fatigue in Multiple Sclerosis: Review of the Literature. Neurorehabilitation and neural repair. https://doi.org/10.1177/1545968306298934
288. Kotwal, A., Duggal, R., Sharma, V., Gupta, A., & Gupta, A. K. (2022). PERIPHERAL NERVOUS SYSTEM DISORDERS: A DIAGNOSTIC APPROACH. Global Journal For Research Analysis. https://doi.org/10.36106/gjra/7505767
289. Koç, A. F., Bozdemir, H., Zorludemir, S., Almak, G., & Özeren, A. (2004). Lafora Body Disease: Clinical, Electrophysiological and Histopathological Findings. TURKISH JOURNAL OF MEDICAL SCIENCES.
290. Kraus, J., Lohmann, H., & Evers, S. (2008). Kognitives Defizit als gutachterlich relevantes, nicht erkanntes Syndrom infolge von Multipler Sklerose. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0028-1100835
291. Krause, C. K. (2022). “Everything Hurts and I’m Weak, Doc”. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197544464.003.0021
292. Kumar, K. (2017). Pediatric Physical Therapy and Latest Developments &amp; its Current Status in India. MOJ Yoga & Physical Therapy. https://doi.org/10.15406/mojypt.2017.02.00011
293. Kumari, D., Chaudhury, S., Ranjan, R., & Priyamvada, R. (2025). Psychotherapies for treating dissociative and conversion disorder. Industrial Psychiatry Journal. https://doi.org/10.4103/ipj.ipj_129_24
294. Kučerová, H. P., Preiss, M., Bartoňová, P., & Přikryl, R. (2010). Kognitivní výkon u depresivní poruchy. Psychiatrie pro praxi.
295. Kırca, N., & Öngen, M. (2020). İNFERTİLİTE VE UYKU KALİTESİ ARASINDAKİ İLİŞKİ. Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi. https://doi.org/10.38136/jgon.697603
296. Labat, J., Riant, T., Robert, R., Amarenco, G., Lefaucheur, J., & Rigaud, J. (2007). Diagnostic criteria for pudendal neuralgia by pudendal nerve entrapment (Nantes criteria). Neurourology and Urodynamics. https://doi.org/10.1002/nau.20505
297. Langlois, S. (2011). Un diagnostic "psy" invisible : le cas du trouble d'adaptation.
298. Larner, A. J. (2012). Neurological Signs of Ageing. Pathy's Principles and Practice of Geriatric Medicine. https://doi.org/10.1002/9781119952930.ch53
299. Lattanzi, S., & Provinciali, L. (2015). Topical Lidocaine for Localized Neuropathic Pain. Archives of Neuroscience. https://doi.org/10.5812/archneurosci.28698
300. Lazare, A. (1981). Conversion Symptoms. New England Journal of Medicine. https://doi.org/10.1056/nejm198109243051306
301. Leclair, N., Leclair, S., & Brigham, C. R. (2002). Multiaxial Diagnosis of Mental and Behavioral Disorders. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2002.novdec01
302. Leggin, B. G., Shaffer, M. A., Neuman, R. M., Williams, G. R., & Annotti, J. P. I. (2003). Relationship of the Penn Shoulder Score with Measures of Range of Motion and Strength in Patients with Shoulder Disorders: A Preliminary Report.
303. Leitão, F., Pinho, S. A., Freitas, J., & Coutinho, F. (2024). Review of Delusional Jealousy and Its Association with Sexual Dysfunctions. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2024.1582
304. Lelyveld, N. V. (2007). Translational research in motor and sensory function of the upper GI tract.
305. Lemogne, C., Pitron, Jy, R., Limosin, F., & Cathébras, P. (2019). What attitude towards a patient with somatoform disorder?. PubMed.
306. Lennox, B. (2008). Neurocognition of depression. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780198569275.003.0021
307. Lenz, G. R., Schoepke, H. G., & Spaulding, T. C. (2000). Anesthetics. Kirk-Othmer Encyclopedia of Chemical Technology. https://doi.org/10.1002/0471238961.0114051912051426.a01
308. Liddle, P. F. (1993). The Psychomotor Disorders: Disorders of the Supervisory Mental Processes. Behavioural Neurology. https://doi.org/10.1155/1993/537458
309. Liddle, P. F. (1993). The psychomotor disorders: disorders of the supervisory mental processes.. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.3233/ben-1993-6102
310. Lieberman, J. S., & Strauss, N. E. (2006). Muscular dystrophy and other myopathies. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545078.043
311. Lievre, J. L., Schweitzer, R., & Barnard, A. (2012). The subjective experience of negative symptoms: Characteristics of emotional withdrawal.
312. Lindenmayer, J. (2000). The pathophysiology of agitation.. PubMed.
313. Lipsitz, L. A. (2004). Physiological Complexity, Aging, and the Path to Frailty. Science of Aging Knowledge Environment. https://doi.org/10.1126/sageke.2004.16.pe16
314. Liu, Y., Zhao, J., Fan, X., & Guo, W. (2019). Dysfunction in Serotonergic and Noradrenergic Systems and Somatic Symptoms in Psychiatric Disorders. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2019.00286
315. Liétor, M. M., Giancola, A. S., Iñiguez, I. C., García, C. Á., & Prieto, M. (2022). Hysteria in neurology: a diagnostic approach to conversive disorder. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2022.1000
316. Lochhead, J. D., Maguire, G. A., & Nelson, M. A. (2018). Pseudobulbar Affect Versus Depression: Issues in Diagnosis and Treatment.
317. Lorusso, A. M., Bruno, S., & L'Abbate, N. (2006). [Occupational fitness of workers with fibromyalgia syndrome].. Giornale italiano di medicina del lavoro ed ergonomia.
318. Louis, E. D. (2013). ‘Essential Tremor' or ‘the Essential Tremors': Is This One Disease or a Family of Diseases?. Neuroepidemiology. https://doi.org/10.1159/000356351
319. Loyola, D. P. (2010). Truques sensoriais em diferentes tipos de distonia e no espasmo hemifacial.
320. Luis, T. J. (2021). Psychotropic drugs prescription block the positive effects of the doctor-patient communication and relationship. Archives of Psychiatry and Mental Health. https://doi.org/10.29328/journal.apmh.1001029
321. Luongo, L., Malcangio, M., Salvemini, D., & Starowicz, K. (2015). Chronic Pain: New Insights in Molecular and Cellular Mechanisms. BioMed Research International. https://doi.org/10.1155/2015/676725
322. Luz, K. P. D. S., & Coronago, V. M. M. O. (2017). A Doença de Parkinson na pessoa Idosa e a Relação com sua Qualidade de Vida. ID on line REVISTA DE PSICOLOGIA. https://doi.org/10.14295/idonline.v11i35.720
323. Luzzi, G. (2003). Male genital pain disorders. Sexual & Relationship Therapy. https://doi.org/10.1080/1468199031000099479
324. Maccioni, F., & Buonocore, V. (2016). MRI of Pelvic Floor Disorders. CRC Press eBooks. https://doi.org/10.1201/b19531-13
325. Machado, G. G., Miranda, E., Moraes, C. S., Balsan, I. S. G., Bonini, L. V., Siqueira, V., Machado, E. L. J. D., Santos, A. D. D., Campelo, I. K. B., Melo, M. J. O. F. D., Conceição, M. V. D. P. D., Lopes, J. D. V., D’Ângelo, I. F. B., Silva, L. R. S., & Oliveira, M. V. A. D. (2024). ANÁLISE DAS TERAPIAS MEDICAMENTOSAS NA CONDUTA DA ESQUIZOFRENIA. Revista Contemporânea. https://doi.org/10.56083/rcv4n5-244
326. Mackel, C. E., Alterman, R. L., Buss, M. K., Reynolds, R. M., Fox, W. C., Spiotta, A. M., Davis, R. B., & Stippler, M. (2022). Moral Distress and Moral Injury Among Attending Neurosurgeons: A National Survey. Neurosurgery. https://doi.org/10.1227/neu.0000000000001921
327. Macleod, A. D. (2007). ML05 WADDELL AND THE DECEIVING PATIENT – IS IT ALL INTENTIONAL?. ANZ Journal of Surgery. https://doi.org/10.1111/j.1445-2197.2007.04123_5.x
328. Madan, A., Frueh, B. C., Fowler, J. C., Stomberg, S., Bradshaw, M. R., Kelly, K. R., Weinstein, B., Luttrell, M., Danner, S. G., & Beidel, D. C. (2020). “Operator syndrome”: A unique constellation of medical and behavioral health-care needs of military special operation forces. The International Journal of Psychiatry in Medicine. https://doi.org/10.1177/0091217420906659
329. Madruga, M. L. L. H., Melo, G. B., Martins, J. M., Aranha, R. E. L. D. B., Marinho, J. C. R. L., Alves, N. T., Estudo, E., Revisão, U., & Literatura, D. (2018). Estudo Eletroencefalográfico De Indivíduos Com Dor Crônica Decorrente Da Fibromialgia: Uma Revisão Da Literatura. Scientific Research and Reviews. https://doi.org/10.28933/srr-2018-06-28100
330. Maina, G., Neni, M. G., Rapicavoli, P., Rosso, G., & Bogetto, F. (2003). I disturbi psichici dovuti a trauma cranico. Minerva psichiatrica e psicologica.
331. Majeske, M., Nistor, V., & Kellner, C. H. (2016). Late‐Life Psychosis. https://doi.org/10.1002/9781118654231.ch35
332. Maldonado, J. R., & Spiegel, D. (2015). Dissociative Disorders. Psychiatry. https://doi.org/10.1002/9781118753378.ch61
333. Malterud, K., & Aamland, A. (2019). Medically unexplained symptoms: are we making progress?. British Journal of General Practice. https://doi.org/10.3399/bjgp19x701885
334. Manica, A., Leães, C. G. S., Frey, B. N., & Juruena, M. F. (1999). The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. https://doi.org/10.1590/s0066-782x1999000800012
335. Manohar, S., Koolwal, A., & Rao, T. S. (2019). Sex and Depression. Journal of Psychosexual Health. https://doi.org/10.1177/2631831818821532
336. Manohar, S., Rao, T. S., Chandran, S., Maheshwari, S., George, M., Rao, S. S., & Sattar, F. A. (2017). Sexual Dysfunctions in Depression. Clinical Depression. https://doi.org/10.4172/2572-0791.1000125
337. Mantere, O., & Vuorilehto, M. (2015). [Recognition of mood disorders].. PubMed.
338. Marcos, D. I. P. (2007). Induced brain activity as indicator of cognitive processes : experimental-methodical analyses and algorithms for online-applications.
339. Margreiter, I., & Ludin, H. P. (1993). [Psychogenic paraplegia/quadriplegia].. PubMed.
340. Mario, S., & Sevilla, A. R. (2019). Estrés diario y calidad de vida en las personas con lesión medular espinal.
341. Marks, V. (2015). Hypoglycaemia and automatism. Medicine Science and the Law. https://doi.org/10.1177/0025802415592110
342. Martelli, M. F., Zasler, N. D., Bush, S. S., & Pickett, T. C. (2006). Assessment of response bias in impairment and disability examinations. Taylor & Francis eBooks. https://doi.org/10.4324/9780203965238-25
343. Martin, T., Brigham, C. R., & Brooks, C. N. (2001). Clinical Update: Evaluation of Low Back Pain. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2001.janfeb02
344. Martino, D., & Macerollo, A. (2020). Neurodevelopmental motor disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198713005.003.0037
345. Marván, M. L., & Contreras, C. M. (1993). El síndrome premenstrual. Salud Mental.
346. Mateo, L. J., Chu, L., Stevens, S. R., Stevens, J., Snell, C. R., Davenport, T. E., & VanNess, J. M. (2020). Post-exertional symptoms distinguish Myalgic Encephalomyelitis/Chronic Fatigue Syndrome subjects from healthy controls. Work. https://doi.org/10.3233/wor-203168
347. Mathias, C. J., & Low, D. A. (2020). Diseases of the autonomic nervous system. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0603
348. Matisz, C. E., & Gruber, A. J. (2020). Neuroinflammatory Remodeling of the Anterior Cingulate Cortex as a Key Driver of Mood Disorders in Gastrointestinal Disease and Disorders. https://doi.org/10.20944/preprints202009.0593.v1
349. Mayberg, H. S., & Lozano, A. M. (2002). Penfield revisited?. Neurology. https://doi.org/10.1212/wnl.59.9.1298
350. McKim, S., & Carson, C. C. (2011). Erectile Dysfunction: Devices. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-916-1_45
351. McKnight, R., Price, J., & Geddes, J. (2019). Conducting the assessment: examining the patient. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0010
352. McKnight, R., Price, J., & Geddes, J. (2019). Introduction to psychiatry. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0005
353. McKnight, R., Price, J., & Geddes, J. (2019). Medically unexplained physical symptoms. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0033
354. Mecarelli, O., & Vicenzini, E. (2019). Brain Death. Clinical Electroencephalography. https://doi.org/10.1007/978-3-030-04573-9_47
355. Mederos, M. M. A., Rojas, A. M., & Hidalgo, A. A. (2012). EVALUACIÓN DE TÉCNICAS ELECTROFISIOLÓGICAS EN EL DIAGNÓSTICO DEL SÍNDROME DEL TÚNEL CARPIANO. DOAJ (DOAJ: Directory of Open Access Journals).
356. Meerwijk, E. L., & Weiss, S. J. (2011). Toward a Unifying Definition of Psychological Pain. Journal of Loss and Trauma. https://doi.org/10.1080/15325024.2011.572044
357. Meeusen, R., Duclos, M., Foster, C., Fry, A. C., Gleeson, M., Nieman, D. C., Raglin, J. S., Rietjens, G., Steinacker, J. M., & Urhausen, A. (2012). Prevention, diagnosis and treatment of the overtraining syndrome: Joint consensus statement of the European College of Sport Science (ECSS) and the American College of Sports Medicine (ACSM). European Journal of Sport Science. https://doi.org/10.1080/17461391.2012.730061
358. Mehta, U. M., & Chaturvedi, S. K. (2022). Somatization. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198861478.003.0044
359. Menefee, D. S., Ledoux, T., & Johnston, C. A. (2022). The Importance of Emotional Regulation in Mental Health. American Journal of Lifestyle Medicine. https://doi.org/10.1177/15598276211049771
360. Micoulaud‐Franchi, J., Lemogne, C., & Quilès, C. (2019). [Definition of somatoform disorders: somatic symptoms or mental symptoms?]. PubMed.
361. Miettinen, O. S., & Flegel, K. M. (2003). Elementary concepts of medicine: VII. Course of illness: manifestations, complications, outcome. Journal of Evaluation in Clinical Practice. https://doi.org/10.1046/j.1365-2753.2003.00420.x
362. Mihaljević-Peleš, A., Janović, M. B., Šagud, M., Živković, M., Janović, Š., & Jevtović, S. (2019). Cognitive deficit in schizophrenia: an overview.. PubMed.
363. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395
364. Mikkelsen, M. E., & Iwashyna, T. J. (2020). Persistent problems and recovery after critical illness. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0395_update_001
365. Milićević, M., & Potić, S. (2012). Functional characteristics of people with cerebral palsy in the adult age. https://doi.org/10.2298/micp2012275m
366. Miller, L. (2000). Neurosensitization: A model for persistent disability in chronic pain, depression, and posttraumatic stress disorder following injury. Neurorehabilitation. https://doi.org/10.3233/nre-2000-14104
367. Miller, M. W., Marx, B. P., & Keane, T. M. (2010). Posttraumatic Stress Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0699
368. Minton, C. A. B., Bruner, S. M., & Morris, C. A. W. (2017). Diagnosis and Treatment of Children and Adolescents. Routledge eBooks. https://doi.org/10.4324/9781315466736-15
369. Mir, J. A., Mushtaq, B., & Mushtaq, O. A. (2022). Clinical case report on bipolar affective disorder, mania. IP Journal of Paediatrics and Nursing Science. https://doi.org/10.18231/j.ijpns.2022.007
370. Mirzaa, G., Conway, R. L., Graham, J. M., & Dobyns, W. B. (2013). PIK3CA-Related Segmental Overgrowth.
371. Misulis, K. E. (2013). Clinical EEG. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199985906.003.0004
372. Misulis, K. E., & Murray, E. L. (2017). Mental Status Change. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190259419.003.0005
373. Miyamoto, S. T., & Valim, V. (2024). Fadiga e dor: manejo farmacológico e não farmacológico. Revista Paulista de Reumatologia. https://doi.org/10.46833/reumatologiasp.2024.23.1.28-31
374. Miyawaki, E. (2001). Are Specific Neurophysiologic Markers Associated with Conversion Disorder. Journal watch. https://doi.org/10.1056/jn200108230000004
375. Morales, D. O. (2019). Muerte encefálica en pediatría..
376. Morin, C. M., & Edinger, J. D. (2008). Sleep/Wake Disorders. https://doi.org/10.1093/oso/9780195374216.003.0019
377. Moritz, S., Silverstein, S. M., Beblo, T., Zonp, Z., Zink, M., & Gallinat, J. (2021). Much of the Neurocognitive Impairment in Schizophrenia is Due to Factors Other Than Schizophrenia Itself: Implications for Research and Treatment. Schizophrenia Bulletin Open. https://doi.org/10.1093/schizbullopen/sgaa034
378. Moshé, S. L., Tuchman, R. F., & Rapin, I. (2005). [Neurodevelopmental disorders and epilepsy].. PubMed.
379. Mosley, M., Macdonald, R. L., Provencio, J. J., Simard, J. M., & James, R. F. (2015). Cognitive Dysfunction and Neuroinflammation After an aSAH. MD Conference Express. https://doi.org/10.1177/1559897715578121
380. Mottron, L., & Burack, J. A. (2012). Sensory, Motor and Attention Characteristics of Autistic Children.
381. Munglani, R. (2000). Neurobiological Mechanisms Underlying Chronic Whiplash Associated Pain: The Peripheral Maintenance of Central Sensitization. Journal of Musculoskeletal Pain. https://doi.org/10.1300/j094v08n01_14
382. Munteanu, D., Vlase, A., Perţea, L., Felea, M. G., Rusu, A., Ciorap, R., & Anton-Prisacariu, B. (2022). Neuropsychic pathology in the context of anterior chest pain. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2022.3.06
383. Muralidharan, K., Rathi, L., Sinha, N., Reddy, P. V., & Bhaskar, M. (2025). Clinical practice guidelines on cognitive impairment in bipolar disorders – Assessment and management. Indian Journal of Psychiatry. https://doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_696_24
384. Møller, A. R. (2001). Symptoms and signs caused by neural plasticity. Neurological Research. https://doi.org/10.1179/016164101101199009
385. Müller, A. (2020). Mental health disorders: prevalent but widely ignored in academia?. The Journal of Physiology. https://doi.org/10.1113/jp279386
386. Nasiri, H., Ebrahimi, A., Zahed, A., Arab, M., & Samouei, R. (2015). Cognitive-analytical therapy for a patient with functional neurological symptom disorder-conversion disorder (psychogenic myopia): A case study. Journal of Research in Medical Sciences. https://doi.org/10.4103/1735-1995.163980
387. Naval, N. S., Chandolu, S., & Mirski, M. A. (2011). Organ Failure: Central Nervous System. Seminars in Respiratory and Critical Care Medicine. https://doi.org/10.1055/s-0031-1287867
388. Navrátil, O., Smrčka, M., & Hanák, P. (2006). Resocialization and quality of life after severe traumaticbrain injury. Journal of Neurotrauma.
389. Neeleman, J., & Mh, D. G. (2006). [Suicidal tendencies, a disorder that crosses boundaries between disciplines].. PubMed.
390. Negreiros, D., Fregni, F., & Scalco, A. Z. (2007). Afasia global sem hemiparesia: AVC ou transtorno conversivo?. Archives of Clinical Psychiatry (São Paulo). https://doi.org/10.1590/s0101-60832007000100004
391. Nesse, R. M., & Stein, D. J. (2012). Towards a genuinely medical model for psychiatric nosology. BMC Medicine. https://doi.org/10.1186/1741-7015-10-5
392. Nicholson, T. R., Carson, A., Edwards, M. J., Goldstein, L. H., Hallett, M., Mildon, B., Nielsen, G., Nicholson, C., Perez, D. L., Pick, S., Stone, J., Anderson, D. G., Asadi‐Pooya, A. A., Aybek, S., Baslet, G., Bloem, B., Brown, R. J., Chalder, T., Damianova, M., ... Tinazzi, M. (2019). Outcome Measures for Functional Neurological Disorder: A Review of the Theoretical Complexities. Journal of Neuropsychiatry. https://doi.org/10.1176/appi.neuropsych.19060128
393. Nieto-Pico, A. M., Rueda-Vargas, A., & Mora-Bautista, V. M. (2019). Trastornos por tics en niños: un caso con retraso diagnóstico. CES Medicina. https://doi.org/10.21615/cesmedicina.33.2.6
394. Nijenhuis, E. R. S. (2022). Somatoform Dissociation, Agency, and Consciousness. Routledge eBooks. https://doi.org/10.4324/9781003057314-40
395. Nishiyama, J., Abe, T., Imaizumi, S., Yamane, A., & Fukunaga, M. (2022). Characteristics of outpatients with functional somatic syndromes at a university hospital's general medicine clinic. Journal of General and Family Medicine. https://doi.org/10.1002/jgf2.543
396. Nizamie, A., Sengupta, U., Mishra, B. R., Praharaj, S. K., & Nizamie, S. H. (2010). Alka Nizamie;Uma Sengupta;Biswa Ranjan Mishra;Samir Kumar Praharaj;S. Haque Nizamie. Acta Neurologica Taiwanica. https://doi.org/10.29819/ant.201003.0008
397. Nonnekes, J., Růžička, E., Serranová, T., Reich, S. G., Bloem, B. R., & Hallett, M. (2020). Functional gait disorders. Neurology. https://doi.org/10.1212/wnl.0000000000009649
398. Northoff, G. (2016). Psychopathology of the self and the altered cortical midline structures in psychiatric disorders – a marriage?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.902
399. Novo, J. P., Perera, A. E., Hernández, D. M. P., Suárez, B. G., & García, A. R. (2013). Enfoque rehabilitador del síndrome de dolor regional complejo tipo I. Revista Cubana de Reumatología: RCuR.
400. Núñez, C., Tobón, S., Vinaccia, S., & Sandín, B. (2006). Evaluación y Terapia Psicológica en la Dispepsia Funcional. Terapia psicológica.
401. Oakley, D. A., Ward, N., Halligan, P. W., & Frackowiak, R. S. J. (2003). Differential brain activations for malingered and subjectively ‘real’ paralysis. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198515548.003.0021
402. Olmedo, A., & Rolando, M. (2015). Informe psicológico pericial: situación de violencia intrafamiliar, “maltrato física, psicológica y sexual”, grado de afectación psicológico..
403. Operto, F. F., Pastorino, G. M. G., Padovano, C., Scuoppo, C., Vivenzio, V., & Coppola, G. (2020). Psychogenic Seizures in Adolescents: An “Evergreen” Diagnostic Challenge. BRAIN BROAD RESEARCH IN ARTIFICIAL INTELLIGENCE AND NEUROSCIENCE. https://doi.org/10.18662/brain/11.3sup1/131
404. Orfei, M. D., Robinson, R. G., Prigatano, G. P., Starkstein, S., Rüsch, N., Bria, P., Caltagirone, C., & Spalletta, G. (2007). Anosognosia for hemiplegia after stroke is a multifaceted phenomenon: a systematic review of the literature. Brain. https://doi.org/10.1093/brain/awm106
405. Otsuki, M. (2012). Cognitive impairment implicated in the damage to the frontal lobe and the basal ganglia. Higher Brain Function Research. https://doi.org/10.2496/hbfr.32.194
406. Ov, F. (1993). [The characteristics of mental disorders in patients with functional disturbances of the large intestine].. PubMed.
407. Ozdemir, D., & Sahni, S. (2019). Conversion Disorder (Functional Neurological Symptom Disorder) Masquerading as Multiple Sclerosis: A Case Report. Cureus. https://doi.org/10.7759/cureus.4893
408. O’Halloran, E., Branagan, A., Canty, N., Michael, O., & Stokes, H. (2019). P407 Conversion disorder: don’t be mistaken, don’t be misled. Abstracts. https://doi.org/10.1136/archdischild-2019-epa.753
409. Pablo, G. S. D. (2018). Mental Capacity and Decision Making in Bipolar Disorder. Peer Reviewed Journal of Forensic & Genetic Sciences. https://doi.org/10.32474/prjfgs.2018.03.000152
410. Pagel, J. (2008). Sleep and dreaming – medication effects and side-effects. CRC Press eBooks. https://doi.org/10.3109/9780203091715-59
411. Paio, F., Antelmi, E., Conti, E., Vico, I. A. D., & Tinazzi, M. (2020). Functional Motor Disorders Mimicking Symptoms Upon Resolution of Cerebrovascular Disease. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.12972
412. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
413. Parker, R. S. (2012). Chronic Posttraumatic Disorders of Consciousness. CRC Press eBooks. https://doi.org/10.1201/b10562-14
414. Parker, R. S. (2012). Introduction to the Postconcussion Syndrome. CRC Press eBooks. https://doi.org/10.1201/b10562-2
415. Pascual‐Leone, Á., Ramachandran, V. S., Cole, J., Sala, S. D., Manly, T., Mayes, A. R., & Sacks, O. (2011). The Paradoxical Brain. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511978098
416. Patel, D. R., & Merrick, J. (2020). Neurodevelopmental and neurobehavioral disorders. Translational Pediatrics. https://doi.org/10.21037/tp.2020.02.03
417. Patil, M. B. (2020). Physical Activity and Sport in Wellbeing: Psycho physiological Perspective. Our Heritage.
418. Patricia, G. C. C., AAngela, G.-M., & Marina, R.-A. (2017). Diagnostic and therapeutical challenges of late-onset psychosis.. Journal of Psychology and Cognition. https://doi.org/10.35841/psychology-cognition.2.4.218-220
419. Peddada, S. P., Allamsetty, J., Godavarthi, S., Matla, I., & Sirasana, L. (2021). Case report on hypoglycemia induced seizures. International Journal of Pharmaceutics and Drug Analysis. https://doi.org/10.47957/ijpda.v9i1.447
420. Pee, D. H., Song, D. J., Shin, Y. K., Lee, J. H., Lee, K. H., Eun, B. L., & Hoon, S. (2001). A Case of Measles Encephalopathy with Thalamic Lesion onMagnetic Resonance Imaging.
421. Pejović-Nikolić, S. (2011). [Neurobiological disturbances in insomnia: clinical utility of objective sleep measures].. PubMed.
422. Pelayo, R., & Sinha, D. (2001). Pharmacotherapy and parasomnias. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511711947.033
423. Perington, M. R., Smith, C. A., & Schillerstrom, J. E. (2019). Decisional Capacity and Personality Disorders: Substantially Unable or Substantially Unwilling?. Journal of Forensic Sciences. https://doi.org/10.1111/1556-4029.14219
424. Pigarova, E., & Rozhinskaya, L. Y. (2010). Sindrom khronicheskoy ustalosti: sovremennye predstavleniya ob etiologii. Obesity and metabolism. https://doi.org/10.14341/2071-8713-4977
425. Pitkanen, M. L., Stevens, T. H., & Kopelman, M. D. (2010). Neuropsychiatric disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.2604
426. Policarpo, A. C. D. F., Garcia, A. P. V., & Faustino, L. (2017). SÍNDROME NEUROLÉPTICA MALIGNA: relato de caso. Percurso Acadêmico. https://doi.org/10.5752/p.2236-0603.2017v7n13p125
427. Poole, J., & Hardie, R. (2019). Neurological disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198808657.003.0023
428. Portes, V. D., & Héron, D. (2020). Trastornos del desarrollo intelectual. Contraste.
429. Posner, J. B., Saper, C. B., Schiff, N. D., & Plum, F. (2008). Multifocal, Diffuse, and Metabolic Brain Diseases Causing Delirium, Stupor, or Coma. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195321319.003.0320
430. Presseau, C., Berke, D. S., Yeterian, J. D., & Litz, B. T. (2020). The Impact of Exposure to Potentially Traumatic Events on Physical Health. The Wiley Encyclopedia of Health Psychology. https://doi.org/10.1002/9781119057840.ch149
431. Pringsheim, T., Chen, R., & Lang, A. E. (2006). Psychogenic motor disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198525769.003.0022
432. Provini, F., Vetrugno, R., & Montagna, P. (2008). Restless legs syndrome: effects on cognitive functioning, memory, and psychomotor performance. CRC Press eBooks. https://doi.org/10.3109/9780203091715-54
433. Pérez, Á. M. S., Granados, F. J. V., Salazar, M. H., Méndez, A. Z., & Dávalos, É. M. (2005). Síndrome prefrontal ventromedial. Reporte de caso. Neurología, Neurocirugía y Psiquiatría.
434. Pérez-Lloret, S., & Barrantes, F. J. (2016). Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson’s disease. npj Parkinson s Disease. https://doi.org/10.1038/npjparkd.2016.1
435. Pérez-Rodríguez, V., Gadea, M. O., Caronna, E., & Urrutia, A. R. (2018). Clínica alucinatoria secundaria a enfermedad médica: características clínicas y manejo. DOAJ (DOAJ: Directory of Open Access Journals). https://doi.org/10.34810/psicosompsiquiatrnum0404
436. Radanovic, M., Stella, F., & Forlenza, O. V. (2015). Comprometimento cognitivo leve Mild cognitive impairment.
437. Radanovic, M., Stella, F., & Forlenza, O. V. (2015). Comprometimento cognitivo leve. Revista de Medicina. https://doi.org/10.11606/issn.1679-9836.v94i3p162-168
438. Realpe, B. L. C. (2013). Estudio comparativo de la acción psicofarmacológica y analgésica de extractos de plantas de uso terapéutico tradicional con antidepresivos inhibidores selectivos de la recaptación de monoaminas.
439. Reich, S. G. (2006). Psychogenic Disorders. Seminars in Neurology. https://doi.org/10.1055/s-2006-945514
440. Reinares, M., Martínez‐Arán, A., & Vieta, E. (2019). Psychoeducation for Patients and Family Members. Cambridge University Press eBooks. https://doi.org/10.1017/9781108589802.004
441. Ressler, K. J., & Nemeroff, C. B. (2000). Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depression and Anxiety. https://doi.org/10.1002/1520-6394(2000)12:1+<2::aid-da2>3.0.co;2-4
442. Richardson, R. F. (2019). Neurobiological Fingerprints of Psychiatric Disorders: An Opportunity to Refine Diagnostic Categorization. Archives in Neurology & Neuroscience. https://doi.org/10.33552/ann.2019.04.000581
443. Riederer, P., Hartmann, J., & Künig, G. (1993). Involvement of transmitter systems in neuropsychiatric diseases. Acta Neurologica Scandinavica. https://doi.org/10.1111/j.1600-0404.1993.tb00015.x
444. Riemann, D., Zerssen, D. V., Berger, M., Dose, M., Doerr, P., Krieg, C. J., Bossert, S., Pirke, K. M., Dolhofer, R., & Müller, O. A. (1986). The nature of neuroendocrine abnormalities in depression: a controversial issue in contemporary psychiatry.. PubMed.
445. Rihab, R., Soukaina, K., Yosra, E. H., Imane, A., & Fatiha, M. (2022). Functional Neurological Symptom Disorder in Adolescents: A Case Report. Scholars Journal of Medical Case Reports. https://doi.org/10.36347/sjmcr.2022.v10i05.008
446. Ristić, A. J., Petrović, I., Vojvodić, N., Janković, S., & Sokić, D. (2004). Phenomenology and psychiatric origin of psychogenic nonepileptic seizures. Srpski arhiv za celokupno lekarstvo. https://doi.org/10.2298/sarh0402022r
447. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2012.0227
448. Ritz, L., Pitel, A., Vabret, F., Eustache, F., & Beaunieux, H. (2012). Alcoolodépendance : atteintes neuropsychologiques et diagnostics différentiels. Revue de neuropsychologie. https://doi.org/10.3917/rne.043.0196
449. Rogers, S., Lilley, J. S., Raynor, G., Hodges, S., & Larson, D. (2024). The Spectrum Between Catatonia and Functional Neurologic Disorder Superimposed on Post-Infectious Encephalitis in a Marine Recruit. Military Medicine. https://doi.org/10.1093/milmed/usae382
450. Rojas, L. F., García, R. S., & Núñez, M. B. (2012). Caracterización de las neuropatías auditivas. Correo Científico Médico.
451. Roland, P. S., & Blau, P. (2016). Diagnosis and Management of Balance Disturbances Following Traumatic Brain Injury. CRC Press eBooks. https://doi.org/10.1201/9781439849828-10
452. Rollnik, J. D., & Adner, A. (2020). Neuropsychologische Langzeitfolgen und Teilhabestörungen nach aneurysmatischer Subarachnoidalblutung (aSAB). Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/a-1003-6756
453. Roobol, M., Swolfs, S. N., Maas, H., & Veth, C. P. M. (2019). [A patient diagnosed with conversion disorder who did not respond to therapy].. PubMed.
454. Ross, J. L., Zinn, A. R., & McCauley, E. (2000). Neurodevelopmental and psychosocial aspects of Turner syndrome. Mental Retardation and Developmental Disabilities Research Reviews. https://doi.org/10.1002/1098-2779(2000)6:2<135::aid-mrdd8>3.0.co;2-k
455. Rostovschikov, V. V., Ivanchuk, E. G., & Rostovschikova, S. I. (2020). The features of psychopathology and cognitive impairments in various variants of the psychoorganic syndrome. Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery). https://doi.org/10.33920/med-01-2009-07
456. Rowe, J. B. (2010). Conversion disorder: understanding the pathogenic links between emotion and motor systems in the brain. Brain. https://doi.org/10.1093/brain/awq096
457. Roy‐Byrne, P. (2001). The Neuroanatomy of Hysterical Paralysis. Journal watch. https://doi.org/10.1056/jp200107260000001
458. Ruff, R. M., Silver, C., Iverson, G. L., BARTH, J., BROSHEK, D., Bush, S. B., Koffler, S. P., & Reynolds, C. W. (2007). Learning disabilities: The need for neuropsychological evaluation. Archives of Clinical Neuropsychology. https://doi.org/10.1016/j.acn.2007.09.006
459. Rzeszut, M., & Assael, R. (2020). Differentiating Depression From Demoralization in Organ Transplantation Recipients. Progress in Transplantation. https://doi.org/10.1177/1526924820978602
460. Sadiq, H., & Abakah, S. (2015). Depression and Its Relation with Blood Group According Differences (Sex).
461. Sahakian, B. J., & Morein‐Zamir, S. (2011). Depression and resilience: insights from cognitive, neuroimaging, and psychopharmacological studies. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199600434.003.0023
462. Saj̈, A. (2011). Les troubles de conversion et les neurosciences cognitives. Revue de neuropsychologie. https://doi.org/10.1684/nrp.2011.0180
463. Salama, A. Z., Dabash, M. R., Elayan, A., Saadeh, S., & Ikhmayyes, I. (2024). Dissociative Trance Led to a Catastrophe: A Case Report. Cureus. https://doi.org/10.7759/cureus.76458
464. Saliba, R., Huber, R., & Penter, J. D. (2011). Controle da dor em pequenos animais. Semina Ciências Agrárias. https://doi.org/10.5433/1679-0359.2011v32n4sup1p1981
465. Sandilyan, M. B., & Dening, T. (2015). Signs and symptoms of dementia. Nursing Standard. https://doi.org/10.7748/ns.29.41.42.e9440
466. Sansone, R. A., & Sansone, L. A. (2010). Medically Unexplainable Somatic Symptoms: A Coat With Many Psychiatric Colors. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.09l00879gre
467. Santos, J. V. C., Santos, M. N. D., & Brito, R. G. D. (2019). FIBROMIALGIA E O SEU IMPACTO NA QUALIDADE DE VIDA DOS PACIENTES. Semana de Pesquisa e Extensão da Universidade Tiradentes - SEMPESq-SEMEX.
468. Sapir, S., & Aronson, A. (1990). The Relationship between Psychopathology and Speech and Language Disorders in Neurologic Patients. Journal of Speech and Hearing Disorders. https://doi.org/10.1044/jshd.5503.503
469. Sato, D. K., & Souza, R. B. D. (2017). Quality of life goes beyond the medical priorities in multiple sclerosis: assessing the impact of social support network. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/0004-282x20170056
470. Savage, G. (2010). Neuropsychological assessment of dementia. CRC Press eBooks. https://doi.org/10.1201/b13196-20
471. Savill, M. (2020). Psychosocial/non-pharmacologic treatment of negative symptoms. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198840121.003.0006
472. Saviluoto, A., Stępień, K. M., Das‐Munshi, J., Cook, A. M., Ocak, U., & Barnacle, J. (2020). Advances in Respiratory Emergencies in Neurological Diseases.
473. Scheitler, K. M., Robin, C. R., & Wijdicks, E. F. M. (2020). Charcot in the ICU: functional tetraplegia after surgery. Practical Neurology. https://doi.org/10.1136/practneurol-2020-002601
474. Schroeder, R. W., Martin, P. K., & Walling, A. (2019). Neuropsychological Evaluations in Adults.. PubMed.
475. Schumacher, S. (2012). Veränderungen somatosensorischer Funktionen bei asymptomatischen PINK1-Mutationsträgern und asymptomatischen PARKIN-Mutationsträgern im Vergleich zu gesunden Kontrollen.
476. Scuccato, R. (2019). [Somatization].. PubMed. https://doi.org/10.1701/3112.31007
477. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
478. Selbæk, G., & Neerland, B. E. (2022). Cognitive decline and dementia: does delirium matter?. The Lancet Healthy Longevity. https://doi.org/10.1016/s2666-7568(22)00056-3
479. Seltzer, B. (2007). Cognitive Complaints: Their Role in Detecting MCI and Dementia.
480. Sen, A., & Johnson, M. R. (2020). Epilepsy in later childhood and adulthood. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198746690.003.0575
481. Seri, S., Cerquiglini, A., & Harding, G. F. A. (2006). Visually induced syncope: A nonepileptic manifestation of visual sensitivity?. Neurology. https://doi.org/10.1212/01.wnl.0000225058.42180.c2
482. Serranová, T. (2022). Functional movement disorders. Neurologie pro praxi. https://doi.org/10.36290/neu.2022.027
483. Setyaningrum, D. A. W. (2019). Cedera olahraga serta penyakit terkait olahraga. Jurnal Biomedika dan Kesehatan. https://doi.org/10.18051/jbiomedkes.2019.v2.39-44
484. Sewell, R. D. E. (2018). Neuropathic pain models and outcome measures: a dual translational challenge. Annals of Translational Medicine. https://doi.org/10.21037/atm.2018.09.58
485. Shaughnessy, A. F. (2020). Some Drugs Slightly Improve Cognition in People with Dementia; Effects on Behavioral or Psychological Symptoms Remain Unclear.. PubMed.
486. Shibasaki, H., Hallett, M., Bhatia, K. P., Reich, S. G., & Balint, B. (2020). Functional (Psychogenic) Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190865047.003.0007
487. Shibasaki, H., Hallett, M., Bhatia, K. P., Reich, S. G., & Balint, B. (2020). Sleep-Related Movement Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190865047.003.0008
488. Silvestri, R., & Aricò, I. (2008). Parasomnias. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511545085.005
489. Sinanović, Š., Prodović, T., Martinović, B., Ratković, M., Stepić, D., Materić, T., & Sekulić, J. (2022). The role of the nurse in the assessment and treatment of pain in oncological patients. Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma. https://doi.org/10.5937/mgiszm2286065s
490. Singh, S. (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
491. Smith, P. J., & Blumenthal, J. A. (2015). Exercise and Physical Activity in the Prevention and Treatment of Depression. Routledge eBooks. https://doi.org/10.4324/9780203132678.ch8
492. Smorag, U., Matthias, N., Fischer, M., Gehrke, A., & Küther, G. (2006). Auftreten seltener psychosomatischer Störungen in der fachübergreifenden Früh-Rehabilitation. Physikalische Medizin Rehabilitationsmedizin Kurortmedizin. https://doi.org/10.1055/s-2006-954388
493. Sobel, D. S. (1995). Rethinking Medicine. Psychosomatic Medicine. https://doi.org/10.1097/00006842-199505000-00005
494. Sokolowski, K., Liu, J., Delatte, M. S., Authier, S., McMaster, O., & Bolon, B. (2024). The Role of Neuropathology Evaluation in the Nonclinical Assessment of Seizure Liability. Toxicologic Pathology. https://doi.org/10.1177/01926233241300065
495. Spence, S. A. (2006). All in the mind? The neural correlates of unexplained physical symptoms. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.12.5.349
496. Spiegel, E. P., & Vanderploeg, R. D. (2010). Postconcussion Syndrome. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0696
497. Spósito, M. M. D. M., & Riberto, M. (2010). Avaliação da funcionalidade da criança com paralisia cerebral espástica.
498. Spósito, M. M. D. M., & Riberto, M. (2010). Functionality evaluation of children with spastic cerebral palsy. Acta Fisiátrica. https://doi.org/10.11606/issn.2317-0190.v17i2a103312
499. Stoeckle, J. D. (1962). Bodily Complaints and Other Symptoms of Depressive Reaction. JAMA. https://doi.org/10.1001/jama.1962.03050150040008
500. Stoica, I.-P. (2021). Psychosocial rehabilitation: a myth or a legitimate field in modern psychiatry?. Psihiatru ro. https://doi.org/10.26416/psih.65.2.2021.5005
501. Stoica, I.-P. (2021). Reabilitarea psihosocială: un mit sau un domeniu legitim în psihiatria modernă?. Psihiatru ro.
502. Stone, J. (2002). Functional weakness and sensory disturbance. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.73.3.241
503. Stone, J. (2024). Incongruence in FND: time for retirement. Practical Neurology. https://doi.org/10.1136/pn-2023-003897
504. Stone, J., & Carson, A. (2015). Conversion Disorder/Functional Neurological Disorder. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp009
505. Stone, J., & Edwards, M. J. (2012). Trick or treat?. Neurology. https://doi.org/10.1212/wnl.0b013e31825fdf63
506. Stone, J., & Sharpe, M. (2020). Functional neurological symptom disorder (conversion disorder). Oxford University Press eBooks. https://doi.org/10.1093/med/9780198713005.003.0133
507. Stone, J., Carson, A., & Sharpe, M. (2005). Functional symptoms in neurology: management. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2004.061663
508. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
509. Sturgeon, J. A., & Martucci, K. T. (2020). Neuroimaging Correlates for Psychological and Chronic Pain Experiences. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190248253.003.0009
510. Stuss, D. T., Gow, C. A., & Hetherington, C. R. (1992). "No longer gage": Frontal lobe dysfunction and emotional changes.. Journal of Consulting and Clinical Psychology. https://doi.org/10.1037//0022-006x.60.3.349
511. Su, N., Yang, J., Xie, Y., Du, X., Chen, H., Zhou, H., & Chen, L. (2019). Bone function, dysfunction and its role in diseases including critical illness. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.27063
512. Sumiyoshi, T., Matsuoka, T., & Kurachi, M. (2012). Role for Pituitary Neuropeptides in Social Behavior Disturbances of Schizophrenia. InTech eBooks. https://doi.org/10.5772/52326
513. Sun, F., Liu, J., Chen, F., Zhu, J., Gao, Z., Ren, Z., Ying, S., Chen, Z., Yongchun, M., Wang, Z., & Jin, W. (2019). Differences in Neurobiology of Different Syndrome of Melancholia in the Viewpoint of TCM. NeuroQuantology. https://doi.org/10.14704/nq.2019.17.5.2369
514. Sunde, K. E., Hilliker, D. R., & Fischer, P. R. (2020). Understanding and Managing Adolescents with Conversion and Functional Disorders. Pediatrics in Review. https://doi.org/10.1542/pir.2019-0042
515. Sutcliffe, M. M. L. (2019). Irritable bowel syndrome. InnovAiT Education and inspiration for general practice. https://doi.org/10.1177/1755738019855099
516. Takada, S. (2020). Prevention and diagnosis of neuropathy during dental treatment. Japanese Journal of Oral & Maxillofacial Surgery. https://doi.org/10.5794/jjoms.66.530
517. Talambas, S., Amaral, M. J., Vieira, A., Rodrigues, M., & Manzano, M. N. S. (2022). Impacto Laboral da Perturbação Obsessivo-Compulsiva: Caso Clínico. Revista Portuguesa de Saúde Ocupacional. https://doi.org/10.31252/rpso.12.02.2022
518. Talman, L., & Pfeiffer, R. F. (2022). Movement Disorders and the Gut: A Review. Movement Disorders Clinical Practice. https://doi.org/10.1002/mdc3.13407
519. Tanaka, M., Török, N., Tóth, F., Szabó, Á., & Vécsei, L. (2021). Co-Players in Chronic Pain: Neuroinflammation and the Tryptophan-Kynurenine Metabolic Pathway. Biomedicines. https://doi.org/10.3390/biomedicines9080897
520. Taniguchi, S., & Takeda, A. (2015). I. New Insights into Symptoms in Parkinson's Disease Including Non Motor Featrures. Nihon Naika Gakkai Zasshi. https://doi.org/10.2169/naika.104.1546
521. Teja, N., Gummadi, O. D., Devi, B. V., & Pavani, N. (2020). Evaluation of Depressant Activity on Mansoa alliacea on Rats. Acta Scientific Pharmaceutical Sciences. https://doi.org/10.31080/asps.2020.04.0617
522. Terçariolli, B. I., Rosa, J. M., Vieira, G. P., Cardoso, R., & Lage, P. S. (2024). RESUMO Introdução: Os transtornos mentais são definidos como sendo síndromes caracterizadas por uma perturbação clinicamente expressiva na cognição, na regulação emocional ou no comportamento de um indivíduo, que refletem uma disfunção nos processos psicológicos, biológicos ou de desenvolvimento subjacentes ao funcionamento mental. Estes estão frequentemente associados ao sofrimento ou às incapacidades. Sabe-se que uma das características marcantes de determinados transtornos está relacionada à…. Revista fisio&terapia.. https://doi.org/10.69849/revistaft/fa1020240911111905
523. Thompson, W., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Müller‐Lissner, S. (1999). Functional bowel disorders and functional abdominal pain. Gut. https://doi.org/10.1136/gut.45.2008.ii43
524. Thomsen, T., & Miyasaki, J. M. (2012). Psychogenic Movement Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-60327-120-2_7
525. Thor, K. B., Kirby, M., & Viktrup, L. (2007). Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine. International Journal of Clinical Practice. https://doi.org/10.1111/j.1742-1241.2007.01433.x
526. Timo, P. (2021). Hallucination: A Mental Illness. Clinical Psychiatry. https://doi.org/10.36648/2471-9854.21.7.81
527. Tito, E., Knapp, B., Bucca, A., & Espiridion, E. D. (2019). A Case Report of Schizoaffective Disorder with Pseudoseizures in a 42-year-old Male. Cureus. https://doi.org/10.7759/cureus.4835
528. Torpy, J. M. (2008). Delirium. JAMA. https://doi.org/10.1001/jama.300.24.2936
529. Torres, M. G., & Gómez–Escalonilla, C. (2017). NEUROCIENCIAS Y DERECHO. Universidad del Externado eBooks. https://doi.org/10.2307/j.ctv18msmv0.7
530. Tougas, G. (2000). The autonomic nervous system in functional bowel disorders. Gut. https://doi.org/10.1136/gut.47.suppl_4.iv78
531. Toyoda, C. Y., & Silva, L. M. F. D. (2015). Orientação domiciliar a familiares e cuidadores de pacientes com acidente vascular encefálico: papel do terapeuta ocupacional.
532. Trzepacz, P. T., & DiMartini, A. F. (2000). Preface. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544385.001
533. Tsapakis, E. M., & Aitchison, K. J. (2008). Biological treatments: general considerations. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544125.026
534. Tso, I. F., Chun, J., & Deldin, P. J. (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
535. Tuchman, R., Moshé, S. L., & Rapin, I. (2005). Trastornos del neurodesarrollo y epilepsia. Revista de Neurología. https://doi.org/10.33588/rn.40s01.2004649
536. Turk, D. C. (2010). Pain Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0629
537. Udangiu, L. N., Roventa, C. E., & Teodorescu, D. (2010). Clinical and Therapeutic Management of Acute Stress Disorder. Management in Health. https://doi.org/10.5233/mih.2010.0013
538. Upton, D., & South, F. (2011). The Psychological Consequences of Wounds - a Vicious Circle that Should not be Overlooked.. Wounds UK.
539. Utiumi, M. A. T., Munhoz, R. P., Cartaxo, C., & Teive, H. A. G. (2012). Complex movement disorder in an elderly patient and the chimera effect. Arquivos de Neuro-Psiquiatria. https://doi.org/10.1590/s0004-282x2012000500014
540. Vaccarino, S. R., & Vaccarino, A. L. (2024). Cognitive Effects of Electroconvulsive Therapy in Schizophrenia. The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.23r15045
541. Valet, M., Gündel, H., Sprenger, T., Sorg, C., Zimmer, C., Hemmer, B., Mühlau, M., & Tölle, T. (2007). Gray-matter alterations in pain processing brain structures in patients with somatoform pain disorder – a voxel-based morphometric study. Aktuelle Neurologie. https://doi.org/10.1055/s-2007-987831
542. Vallat‐Azouvi, C., & Chardin-Lafont, M. (2012). Les troubles neuropsychologiques des traumatisés crâniens sévères. L information psychiatrique. https://doi.org/10.1684/ipe.2012.0933
543. Valls‐Solé, J. (2016). The utility of electrodiagnostic tests for the assessment of medically unexplained weakness and sensory deficit. Clinical Neurophysiology Practice. https://doi.org/10.1016/j.cnp.2016.02.002
544. Vandvik, I. H., & Skjeldal, O. H. (1994). [Conversion disorders in children and adolescents. A multidisciplinary approach].. PubMed.
545. Vataja, R., & Leppävuori, A. (2012). [Assessment and treatment of conversion disorder: the most fascinating borderline of psychiatry and neurology].. PubMed.
546. Ventriglio, A., Gentile, A. J., Baldessarini, R. J., & Bellomo, A. (2015). Early-Life Stress and Psychiatric Disorders: Epidemiology, Neurobiology and Innovative Pharmacological Targets. Current Pharmaceutical Design. https://doi.org/10.2174/1381612821666150105121244
547. Vermeulen, M., & Linden, E. A. M. V. D. (2012). [Conversion disorder].. PubMed.
548. Vitiello, B., Zuddas, A., & Masi, G. (2006). Pharmacologic treatment of children and adolescents with attention deficit hyperactivity disorder. CRC Press eBooks. https://doi.org/10.1201/b14454-11
549. Vizcaíno-Cárdenas, G. S., Conde, L. G. R., & Vizcaíno-Cárdenas, T. A. (2022). Factores Asociados a la Carga Mental en Docentes de Instituciones Educativas Ecuatorianas. Mediciencias UTA (Impresa)/Mediciencias UTA (En línea). https://doi.org/10.31243/mdc.uta.v6i2.1631.2022
550. Vohs, J. L., George, S., Leonhardt, B. L., & Lysaker, P. H. (2016). An integrative model of the impairments in insight in schizophrenia: emerging research on causal factors and treatments. Expert Review of Neurotherapeutics. https://doi.org/10.1080/14737175.2016.1199275
551. Víu, C. M. D., & Blasco, J. M. (2011). Salud laboral y salud mental: estado de la cuestión. Medicina y Seguridad del Trabajo. https://doi.org/10.4321/s0465-546x2011000500001
552. Waechter, S. (2012). Fahren mit Parkinson - Erfahrungen mit aerztlich begleiteten Kontrollfahrten in Zuerich, Schweiz. SCHRIFTENREIHE FAHREIGNUNG.
553. Wallner, R., Senczyszyn, A., Budrewićz, S., & Rymaszewska, J. (2019). Zaburzenia poznawcze i neuropsychiatryczne w chorobie Parkinsona. Polski Przegląd Neurologiczny. https://doi.org/10.5603/ppn.2019.0018
554. Walser, H. (1993). ["Functional" disorders--from the viewpoint of the neurologist].. PubMed.
555. Walther, M., & Woods, D. W. (2010). Trichotillomania. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy1011
556. Wang, D., Wang, Y., Pan, J., & Tian, W. (2020). Neurotrophic effects of dental pulp stem cells in repair of peripheral nerve after crush injury. World Journal of Stem Cells. https://doi.org/10.4252/wjsc.v12.i10.1196
557. Ward, R., & Manchip, S. (2012). ‘Inappropriate’ sexual behaviours in dementia. Reviews in Clinical Gerontology. https://doi.org/10.1017/s0959259812000196
558. Wehrman, E. C. (2022). Grief/Bereavement. The International Encyclopedia of Health Communication. https://doi.org/10.1002/9781119678816.iehc0883
559. Welsh‐Bohmer, K. A., Attix, D. K., & Mason, D. J. (2020). The Clinical Utility of Neuropsychological Evaluation of Patients with Known or Suspected Dementia. Psychology Press eBooks. https://doi.org/10.4324/9781315787039-13
560. Wibawa, P., O’Connor, R., Kenchaiah, B. K., & Velakoulis, D. (2022). Motor Neuron Disease &amp; Frontotemporal Dementia Presenting with a Conversion Disorder. Psychiatry Research Case Reports. https://doi.org/10.1016/j.psycr.2022.100082
561. Willis, M. (2020). #WordsMatter—Communicating the voluntary‐to‐involuntary spectrum in conversion disorder. The Brown University Child and Adolescent Behavior Letter. https://doi.org/10.1002/cbl.30460
562. Worthen, R. J., & Beurel, E. (2022). Inflammatory and neurodegenerative pathophysiology implicated in postpartum depression. Neurobiology of Disease. https://doi.org/10.1016/j.nbd.2022.105646
563. Yadav, A. K., Sharma, S., Choudhary, P. K., & Sharma, R. (2022). The effectiveness of homoeopathic medicines in the management of narcolepsy. International Journal of Homoeopathic Sciences. https://doi.org/10.33545/26164485.2022.v6.i4c.652
564. Yager, J. (2015). Cholinergic and Anticholinergic Balances Affect Working Memory in Schizophrenia. Journal watch. https://doi.org/10.1056/nejm-jw.na37521
565. Yan, R. M., Cardonne, M. M., Reyes, E. J. M., & Leyva, A. G. (2022). Herramienta para la obtención de Patrones de Conectividad Cerebral en Pacientes con Deterioro Cognitivo. Orange Journal. https://doi.org/10.46502/issn.2710-995x/2021.6.04
566. Yang, J., Liu, Z., Pan, Y., Fan, Z., Cheng, Y., Wang, F., Sun, F., Wu, G., Ouyang, X., Tao, H., Yang, J., & Palaniyappan, L. (2024). Regional neural functional efficiency across schizophrenia, bipolar disorder, and major depressive disorder: a transdiagnostic resting-state fMRI study. Psychological Medicine. https://doi.org/10.1017/s0033291724001685
567. Yohannes, A. M., & Baldwin, R. (2008). Medical Comorbidities in Late-Life Depression.
568. Young, W. B., Packard, R. C., & Katsarava, Z. (2007). Headaches Associated with Head Trauma. https://doi.org/10.1093/oso/9780195326567.003.0016
569. Yutzy, S. H. (2015). Somatic Symptom and Related Disorders: Somatic Symptom Disorder, Illness Anxiety Disorder, and Conversion Disorder. Psychiatry. https://doi.org/10.1002/9781118753378.ch62
570. Yutzy, S. H., & Parish, B. (2008). Somatoform Disorders. Psychiatry. https://doi.org/10.1002/9780470515167.ch74
571. Yönt, Y. D. D. H., & Korhan, A. G. D. E. A. (2010). İnmeli Hastalarda İhmal Edilen Bir Sorun: Patolojik Gülme ve Ağlama. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi.
572. Zschucke, E., Gaudlitz, K., & Ströhle, A. (2013). Exercise and Physical Activity in Mental Disorders: Clinical and Experimental Evidence. Journal of Preventive Medicine and Public Health. https://doi.org/10.3961/jpmph.2013.46.s.s12
573. Éb, A., & Év, B. (2004). [Interaction of psychoemotional state and activity of the immune system].. PubMed.
574. Éb, A., & Év, B. (2004). [The role of immunological factor in pharmacology of anxiolytic drugs and antidepressants].. PubMed.
575. Češková, E., & Kučerová, H. P. (2018). Kognitivní dysfunkce u deprese.
576. Řezaninová, J., Dopitová, K., Králová, D. M., & Dovrtělová, L. (2015). Problematika hypermobility ve sportu. Studia sportiva. https://doi.org/10.5817/sts2015-2-6